rfhg_208788.1

Basic information about the TSS

---

TSS ID: rfhg_208788.1 Species: human Chr: chr19		Start: 15332323 End: 15332333 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3045176,EH38E1941864)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC000156:0 GeneID: 23476 HGNC/MGI_ID: HGNC:13575 UniProt_ID: Nearer transcript ids and distances: ENST00000597315.5:-110 BC038988:-162 BC067129:-166 BC091649:-182 BC047888:-198 ENST00000679869.1:-206 NM_001379291.1:-206 NM_001379292.1:-206 NM_001330384.2:-206 LF210778:-210 MA446355:-210 BC035266:-210 ENST00000360016.9:-212 ENST00000601941.1:416 ENST00000594841.5:417 AK307664:417 BC030158:433 view more...

Gene_name: bromodomain containing 4 Gene_symbol: BRD4 Gene_synonyms: CAP HUNK1 HUNKI MCAP Gene_source: HGNC:13575

TATA-Box annotation

---

Distance to TSS:	211
Nearest PromoterID:	NM_001330384
Entrez ID:	23476
Nearest Unigene:	Hs.187763
Nearest Refseq:	NM_014299
Nearest Ensembl:	ENSG00000141867
Gene Name:	bromodomain containing 4
Gene Alias:	CAP|HUNK1|HUNKI|MCAP
Gene Type:	protein-coding
CpG%:	0.300000
GC%:	0.909091
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BRD4 p2@BRD4 p3@BRD4 p5@BRD4 p6@BRD4 p7@BRD4 p8@BRD4
Sample		p1@BRD4	p2@BRD4	p3@BRD4	p5@BRD4	p6@BRD4	p7@BRD4	p8@BRD4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	36.82	12.08	1.17	0.19	4.29	4.48	3.31
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	45.52	15.38	0.20	0.40	4.45	4.65	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	48.23	15.24	0.19	0.58	6.94	4.82	2.70
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	38.05	12.27	0.62	0.21	4.99	3.95	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	43.42	13.72	0.67	0.00	3.37	3.60	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	44.58	14.34	1.36	0.58	4.26	3.88	2.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	43.79	18.30	0.44	0.22	4.14	6.54	4.79
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	36.82	16.96	1.45	0.73	3.15	2.42	3.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	34.62	14.32	0.43	0.21	2.56	3.42	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	49.85	8.69	0.00	0.00	2.32	0.58	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	36.79	8.08	1.21	0.00	2.43	1.21	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	35.78	9.76	0.81	0.00	2.85	1.22	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.93	8.70	1.13	0.16	0.81	1.13	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.92	8.57	0.75	0.30	2.10	1.35	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.46	7.25	0.44	0.22	1.10	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.56	6.29	1.01	0.25	0.75	1.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	4.37	6.12	0.44	0.00	1.53	0.87	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3.80	7.17	0.42	0.00	1.27	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	6.40	1.07	0.00	0.53	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.22	8.12	0.15	0.15	0.75	0.90	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	7.08	10.96	0.80	0.27	1.60	0.94	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.46	9.84	1.04	0.52	1.21	0.00	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.63	8.14	0.65	0.26	1.29	0.90	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.04	5.10	0.49	0.00	1.70	0.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.06	7.48	0.00	0.26	1.55	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.50	6.65	0.63	0.00	1.27	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	14.29	1.65	0.00	2.20	1.10	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.02	10.61	1.41	0.00	1.65	2.59	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.82	7.91	1.13	0.32	0.65	0.81	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.04	8.87	0.90	0.18	1.45	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.84	6.49	0.42	0.21	0.84	1.26	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.21	8.40	0.39	0.39	1.17	0.59	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.18	11.18	0.00	0.00	1.27	1.06	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.06	8.25	0.49	0.49	1.81	1.15	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.72	7.85	0.75	0.19	2.24	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.01	5.56	0.38	0.00	0.77	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.42	8.58	1.23	0.61	1.84	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.69	6.25	0.20	0.20	1.01	1.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	10.53	9.18	0.54	0.54	1.08	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.40	6.96	0.48	0.24	2.64	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.00	5.41	0.00	0.00	0.47	0.24	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.22	6.88	0.44	0.44	1.46	1.90	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.54	6.54	0.84	0.21	1.48	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.97	10.14	1.22	0.17	1.40	0.70	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.04	7.03	0.80	0.20	0.60	1.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.31	6.51	0.47	0.00	1.63	1.40	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.08	8.16	0.00	0.00	1.20	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	7.45	1.19	0.30	0.30	1.19	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.49	8.86	0.48	0.00	0.72	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.51	9.50	0.81	0.20	0.40	0.81	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.89	6.97	0.82	0.00	0.61	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.90	7.78	1.33	0.67	1.78	1.33	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	13.99	13.99	55.97	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	5.32	0.35	0.00	1.77	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.94	7.29	0.66	0.00	0.66	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	13.42	1.68	0.00	6.71	9.23	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	6.43	7.81	0.46	0.00	0.92	2.76	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.81	6.16	0.32	0.00	0.32	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.39	6.10	0.64	0.00	0.32	1.28	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.97	8.17	1.26	0.63	1.26	4.40	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	4.94	0.00	0.00	2.12	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.85	5.05	0.56	0.56	2.80	2.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	7.96	6.37	0.80	2.39	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.47	5.10	2.04	0.34	1.02	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.82	8.77	0.32	0.32	1.95	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.74	3.90	0.35	0.00	1.06	1.77	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	16.16	32.33	32.33	64.66	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	23.69	7.90	0.00	23.69	31.59	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.88	4.88	0.00	0.00	1.46	2.44	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4.96	3.47	0.99	0.00	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	6.57	0.00	0.00	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1.66	4.97	1.32	0.00	1.32	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.95	3.71	0.62	0.00	1.55	0.31	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.42	5.81	0.31	0.31	2.14	0.92	1.53
Adipocyte - breast, donor1	11376-118A8	9.66	3.48	0.16	0.00	0.79	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	6.74	8.18	0.32	0.32	0.80	2.09	0.64
Adipocyte - omental, donor1	11473-119C6	10.05	10.05	0.38	0.00	0.38	0.64	0.51
Adipocyte - omental, donor2	11474-119C7	1.49	2.24	0.00	0.00	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	2.68	3.68	0.33	0.00	1.00	1.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	1.28	1.28	0.00	0.00	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	1.81	0.90	0.45	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.52	9.56	1.56	0.17	2.43	1.04	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	22.69	22.49	2.54	0.78	2.35	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	6.95	10.04	2.06	0.00	1.80	1.03	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	10.59	8.64	1.95	0.00	1.67	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	13.52	7.64	3.53	0.00	1.76	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	16.25	15.04	1.45	0.16	2.25	0.97	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	12.59	8.07	0.97	0.00	2.26	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	8.00	0.53	0.53	1.07	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	3.90	7.23	1.11	0.00	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	6.24	6.65	0.83	0.42	1.25	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	5.27	4.27	0.50	0.00	1.26	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	4.58	4.25	0.00	0.00	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	5.78	4.87	0.61	0.00	0.91	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	17.24	9.94	2.21	0.66	2.21	1.77	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	11.83	11.47	1.08	0.72	4.66	2.87	3.59
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	13.18	2.40	0.00	5.99	3.59	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	12.05	12.77	1.62	0.36	4.50	2.34	3.06
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	8.37	0.00	0.00	5.02	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	10.68	13.15	1.44	0.00	3.08	0.82	1.23
Anulus Pulposus Cell, donor1	11248-116E6	4.58	4.58	1.14	0.00	2.86	0.80	0.57
Anulus Pulposus Cell, donor2	11463-119B5	2.94	6.12	0.73	0.00	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.49	2.70	0.00	0.00	1.80	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.21	4.34	0.43	0.00	2.60	2.17	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	2.39	2.39	0.60	0.60	2.99	0.60	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	5.06	0.00	0.00	6.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.98	2.64	0.66	0.00	0.66	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.55	2.60	0.00	0.00	0.32	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	1.46	3.88	0.49	0.00	1.94	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1.78	4.16	0.00	0.00	2.38	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	3.77	2.64	0.38	0.00	0.75	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	1.45	2.90	0.73	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	1.25	1.25	0.00	2.51	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.28	3.13	0.16	0.16	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	4.09	0.00	0.00	2.73	0.00	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	2.71	2.26	0.15	0.00	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.75	3.75	0.54	0.00	2.68	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.78	2.27	0.94	0.00	0.57	0.38	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	2.41	4.54	0.27	0.00	1.60	1.07	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	0.98	2.93	0.00	0.00	2.93	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	3.65	4.31	0.33	0.00	0.83	1.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1.20	2.40	0.00	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.46	3.95	0.69	0.51	1.72	0.86	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	0.97	0.49	0.49	0.00	2.43	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.55	5.31	0.38	0.00	1.14	0.00	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	2.42	0.00	0.00	2.42	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.99	0.57	0.00	0.57	1.14	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	3.42	2.78	0.64	0.00	0.64	0.86	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	2.32	3.87	0.00	0.26	1.03	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	4.69	0.00	0.00	1.88	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1.93	2.57	0.32	0.00	0.96	0.96	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	2.85	0.00	0.00	0.00	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1.75	0.00	0.58	0.00	1.17	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	3.31	3.61	1.20	0.00	0.90	0.00	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	1.19	2.38	0.00	0.00	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	1.53	0.00	0.00	0.00	1.53	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	3.57	1.78	0.76	0.25	2.04	0.51	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	1.91	0.00	0.00	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	2.59	2.16	0.86	0.43	0.43	0.86	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	3.39	3.18	0.64	0.00	1.06	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.61	4.06	0.29	0.00	1.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	2.83	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.56	4.75	0.85	0.17	1.19	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	4.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.79	3.65	0.86	0.43	1.72	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	1.80	1.20	0.00	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	2.19	2.19	1.46	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.29	3.22	0.46	0.00	1.38	1.15	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	0.00	0.00	2.55	7.65	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1.78	3.05	0.25	0.00	0.76	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.95	3.72	0.62	0.00	1.65	1.03	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	2.75	5.20	0.31	0.00	0.92	0.61	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.26	0.96	0.48	0.00	0.48	2.39	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2.44	3.77	0.67	0.00	0.67	1.11	1.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	0.00	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1.66	4.43	0.55	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4.77	3.97	0.26	0.00	0.79	1.06	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	2.91	5.09	0.36	0.00	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	21.74	15.47	1.72	0.12	6.39	4.05	1.84
Astrocyte - cerebellum, donor2	11580-120F5	13.18	14.89	1.20	0.34	4.45	2.23	1.20
Astrocyte - cerebellum, donor3	11661-122F5	20.56	13.42	3.15	0.00	5.45	0.84	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	17.43	10.46	0.70	0.00	1.05	1.39	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	17.47	15.04	1.62	0.81	4.04	2.75	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	18.94	16.41	1.64	0.45	3.43	1.79	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	22.25	33.72	1.61	0.69	8.60	5.16	1.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	25.68	35.71	2.00	1.75	10.15	3.63	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.21	35.73	1.82	1.02	7.06	3.41	0.68
Basophils, donor1	12241-129G9	22.49	14.91	1.83	0.00	1.05	0.00	0.00
Basophils, donor2	12242-129H1	28.86	23.09	1.08	0.72	1.80	0.72	0.00
Basophils, donor3	12243-129H2	37.48	18.23	2.79	0.29	0.59	0.59	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	5.61	6.68	1.51	0.00	1.94	1.08	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	9.60	0.46	0.46	3.66	1.37	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	14.35	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	5.65	0.63	0.00	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.99	9.77	1.25	0.42	1.04	0.83	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.36	11.05	3.68	0.23	2.30	1.61	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	1.62	7.92	1.80	0.54	1.98	1.62	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	23.91	15.56	0.93	0.41	3.81	2.37	2.68
Burkitt's lymphoma cell line:RAJI	10476-106I8	28.41	21.89	2.10	0.70	5.36	2.10	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	14.39	8.63	0.32	0.00	1.60	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	41.37	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	36.07	34.94	0.56	0.56	1.13	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	41.76	26.17	1.11	0.37	5.20	1.67	0.93
CD14+ Monocytes, donor3	11381-118B4	38.64	23.27	1.32	0.00	2.41	2.20	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.23	12.45	1.13	0.28	0.85	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	7.96	17.82	0.38	0.00	3.03	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	8.22	27.61	1.64	1.31	2.96	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	33.39	23.27	0.58	0.14	3.18	1.88	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	21.12	22.03	0.91	0.00	1.51	0.91	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	25.82	22.74	2.13	0.00	3.32	1.90	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	24.61	23.77	1.00	0.17	2.51	1.17	1.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.74	16.56	0.28	0.83	2.21	1.66	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	25.78	17.36	0.00	0.74	2.23	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	17.82	21.15	0.78	0.59	3.72	1.17	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.61	25.28	0.71	0.36	2.31	1.25	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	13.49	14.80	0.44	0.22	1.09	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	20.84	26.92	1.87	0.70	2.58	0.47	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	26.40	34.85	2.11	0.00	1.06	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	13.31	0.00	0.00	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	27.07	24.99	0.59	0.45	2.97	2.38	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	19.16	17.96	1.40	0.00	2.20	2.59	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	15.41	10.41	0.42	0.00	0.83	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	29.06	26.77	1.37	0.00	2.75	2.75	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	24.43	15.83	0.90	0.00	2.26	0.68	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	27.93	20.95	0.44	0.00	1.75	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	22.60	18.29	1.08	0.81	4.03	1.61	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	24.25	22.33	1.57	0.00	2.27	1.05	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	24.83	23.99	1.26	0.00	2.10	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	21.13	21.86	0.73	0.73	2.57	2.39	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	26.42	32.06	1.41	0.00	1.06	1.41	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	21.50	24.13	0.44	0.44	2.19	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.58	21.10	0.70	0.35	1.57	1.22	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	21.19	23.04	0.00	0.00	1.49	2.23	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	15.95	18.32	0.65	0.22	1.08	0.65	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	21.70	20.47	0.41	0.00	3.28	2.46	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.70	16.69	0.70	0.00	0.93	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.17	14.15	0.23	0.00	0.46	1.62	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	5.89	4.80	0.44	0.00	0.22	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	8.32	3.70	0.23	0.23	1.15	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	6.07	6.72	0.22	0.00	0.65	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	10.43	14.64	0.31	0.00	1.71	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	8.56	6.81	0.35	0.00	1.75	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	17.61	23.41	1.34	0.45	0.67	1.78	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	15.82	7.66	0.77	0.00	1.28	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	12.95	3.51	0.66	0.22	0.66	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	6.53	5.68	0.42	0.42	1.47	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	8.13	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.81	23.73	1.36	0.00	1.36	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	14.50	18.64	1.04	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.99	23.99	0.53	0.00	1.07	0.53	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	16.62	21.44	1.07	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.93	20.36	1.40	0.00	2.11	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	12.55	15.69	0.78	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	26.37	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	86.30	41.92	2.47	0.00	3.29	5.75	2.47
CD19+ B Cells, donor2	11624-122B4	60.21	23.94	1.45	0.00	5.80	2.90	5.08
CD19+ B Cells, donor3	11705-123B4	72.69	29.28	3.03	0.50	10.60	4.04	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	42.43	31.52	0.00	0.81	9.70	2.02	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	31.56	15.98	0.80	0.80	2.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	28.11	7.03	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	49.44	16.29	1.12	0.00	2.25	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	11.65	13.15	0.75	0.00	0.38	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	12.40	11.05	0.68	0.45	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	83.91	43.20	1.07	1.07	4.28	4.64	4.64
CD4+ T Cells, donor2	11306-117C1	56.95	26.94	3.06	0.61	12.25	9.80	0.00
CD4+ T Cells, donor3	11382-118B5	47.27	33.24	1.83	0.91	5.18	4.88	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.25	11.49	0.77	0.00	1.79	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	10.11	16.62	1.12	0.00	0.67	0.67	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	11.79	19.83	0.86	0.29	1.44	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	25.60	16.59	0.00	0.95	0.47	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	22.47	17.56	2.81	0.00	0.00	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	16.48	0.00	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	10.55	7.51	0.58	0.00	1.45	1.01	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	11.02	17.96	1.19	0.34	0.85	1.53	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	11.12	16.28	0.64	0.16	2.10	1.13	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	9.86	9.86	0.00	0.45	1.34	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	13.63	8.04	0.35	0.35	2.10	1.05	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	13.20	15.84	0.88	0.00	2.20	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.81	8.01	0.00	0.00	2.11	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	11.64	17.45	0.83	0.21	2.29	2.70	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	9.36	13.37	0.67	0.33	1.00	1.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	25.83	26.92	0.27	0.54	2.45	1.09	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.01	16.08	1.61	0.00	2.14	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	28.69	25.11	0.00	0.00	3.59	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.72	12.79	0.19	0.19	1.85	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	11.05	16.03	0.65	0.00	1.95	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	11.35	13.45	0.84	0.00	0.84	0.84	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.19	12.13	2.53	0.00	1.52	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	14.30	11.26	0.43	0.00	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	19.61	20.48	2.18	0.44	1.31	2.18	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	8.41	23.26	1.98	0.99	0.99	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	7.39	16.62	0.92	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	12.56	27.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	9.14	16.06	0.83	0.28	1.38	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	10.06	21.84	0.98	0.00	1.72	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	21.56	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	10.74	22.20	0.72	0.72	1.43	1.07	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	6.92	34.62	2.77	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	51.73	27.17	1.31	0.98	3.60	1.64	1.96
CD8+ T Cells, donor2	11307-117C2	48.81	24.40	1.13	0.38	3.00	5.63	1.88
CD8+ T Cells, donor3	11383-118B6	76.50	38.13	2.02	1.01	8.58	5.05	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.18	8.72	0.00	0.23	2.52	2.52	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.59	9.83	0.96	0.00	3.35	4.31	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.13	9.58	0.27	0.27	4.65	3.01	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.90	4.80	0.30	0.30	4.20	2.10	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.68	12.72	1.44	0.00	2.16	1.92	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.87	9.78	0.68	0.00	2.50	2.73	2.50
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	12.82	9.34	0.00	0.00	2.39	2.39	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.69	10.79	0.79	0.26	1.05	1.32	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.08	12.66	0.47	0.70	2.35	2.58	3.52
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.09	12.98	0.60	0.60	2.11	2.11	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.62	9.88	0.58	0.58	2.32	0.87	3.49
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.06	8.53	0.27	0.27	4.00	1.33	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.07	11.38	0.00	0.00	2.63	0.88	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.03	11.39	1.37	0.00	0.91	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	16.41	0.75	0.00	0.75	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.44	8.28	0.00	0.36	1.08	1.44	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.37	12.37	1.15	0.00	0.86	2.01	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.38	13.20	0.00	0.24	1.89	0.71	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.77	14.26	0.95	0.32	2.85	3.17	3.17
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	9.53	0.00	0.31	2.77	0.62	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.54	14.11	0.32	0.32	5.45	2.89	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.45	9.18	0.38	0.38	1.53	0.00	3.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.16	7.88	0.79	0.00	3.15	1.58	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	11.35	10.59	0.76	0.00	2.27	3.03	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	22.48	23.29	1.61	0.80	2.41	2.41	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.98	23.78	2.10	0.00	0.70	0.00	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	29.05	34.06	0.00	0.00	9.02	4.01	6.01
Cardiac Myocyte, donor1	11525-119I4	18.28	1.83	1.83	0.00	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	5.43	5.43	0.49	0.00	0.00	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	5.16	4.74	0.32	0.11	0.84	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	6.93	4.16	0.00	0.00	1.73	1.04	1.39
Chondrocyte - de diff, donor2	11338-117F6	10.66	8.17	0.71	0.00	0.36	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	6.71	9.10	0.80	0.34	1.71	1.82	1.37
Chondrocyte - re diff, donor2	11339-117F7	25.96	10.74	0.90	0.00	4.48	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	14.15	16.98	2.02	0.81	2.02	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	17.79	9.87	1.03	0.11	2.87	1.26	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	8.76	8.12	1.50	0.43	3.21	2.14	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	18.58	14.96	2.30	0.35	2.83	0.80	1.59
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.75	31.73	3.03	0.92	8.34	2.02	0.55
Corneal Epithelial Cells, donor1	11526-119I5	12.74	12.52	1.10	0.88	2.63	1.54	2.20
Corneal Epithelial Cells, donor2	11606-120I4	4.55	9.10	0.00	0.00	4.55	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.44	8.18	0.51	0.00	2.05	1.02	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.67	14.20	0.50	0.17	1.65	0.83	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	15.14	13.25	0.32	0.00	0.32	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.13	9.18	0.32	0.32	1.62	0.97	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	58.42	14.35	0.68	0.00	1.71	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	41.13	7.83	0.65	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	34.84	10.65	0.00	0.00	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	27.02	11.34	2.84	0.00	1.50	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	6.45	7.04	1.17	0.00	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	17.53	16.97	0.85	0.28	2.26	1.98	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	19.27	16.91	2.36	0.39	1.97	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	11.63	11.63	1.75	0.29	2.33	0.87	1.75
Endothelial Cells - Artery, donor2	11341-117F9	17.88	12.23	1.65	1.41	3.53	2.12	2.35
Endothelial Cells - Artery, donor3	11413-118E9	19.63	19.28	1.93	0.18	1.40	1.40	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.87	8.20	0.89	0.44	1.99	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.91	13.39	1.83	0.00	0.61	1.52	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.25	16.63	0.85	0.56	1.13	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	9.51	2.08	0.00	0.89	1.78	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	7.81	0.00	0.00	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.08	13.19	0.57	0.43	3.26	0.57	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	8.40	12.40	2.00	0.00	2.40	2.40	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	12.58	1.05	0.52	2.10	1.57	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	25.10	23.61	2.24	0.75	4.60	1.99	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	19.55	23.46	2.82	0.43	3.26	0.65	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	28.46	29.31	2.69	0.85	3.42	1.22	0.61
Endothelial Cells - Vein, donor1	11267-116G7	17.06	12.51	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	17.46	0.00	0.00	1.40	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	14.13	16.64	1.57	0.16	2.20	0.79	0.16
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	216.18	171.63	0.00	1.65	4.95	4.95	0.00
Eosinophils, donor3	12246-129H5	214.01	121.27	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.80	11.48	0.49	0.24	1.95	2.93	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	18.72	0.00	0.00	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.60	11.49	2.46	0.00	1.23	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.28	2.52	0.33	0.00	0.55	0.77	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.34	4.44	0.65	0.33	3.47	4.23	2.82
Fibroblast - Aortic Adventitial, donor1	11245-116E3	10.43	7.52	1.33	0.24	2.18	1.33	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	5.60	7.10	0.82	0.00	0.96	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.70	9.91	1.58	0.42	2.00	1.69	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	4.48	5.53	1.05	0.00	1.32	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	11.63	9.30	1.99	0.33	2.99	1.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	9.98	6.35	0.91	0.45	1.81	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.19	11.37	0.76	0.00	3.79	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	15.30	8.67	1.26	0.47	1.58	0.95	0.95
Fibroblast - Cardiac, donor4	11452-119A3	10.00	14.25	1.82	0.91	0.91	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	9.14	13.20	2.16	0.63	3.43	0.89	0.00
Fibroblast - Cardiac, donor6	11460-119B2	4.85	12.43	0.91	0.15	2.27	1.36	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.08	10.45	2.28	0.27	2.95	2.95	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	8.20	2.16	0.00	0.86	1.29	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	7.32	2.93	0.00	7.32	0.00	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	63.89	45.67	7.38	0.46	8.07	6.92	3.46
Fibroblast - Conjunctival, donor3	11692-122I9	2.54	7.29	0.68	0.00	2.20	1.36	1.53
Fibroblast - Dermal, donor1	11269-116G9	4.93	4.93	0.70	0.00	1.17	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	9.43	8.49	1.42	0.00	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.47	5.44	1.33	0.12	1.69	0.85	1.33
Fibroblast - Dermal, donor4	11450-119A1	7.35	12.10	1.47	0.11	2.37	0.90	0.45
Fibroblast - Dermal, donor5	11454-119A5	12.21	12.21	1.22	0.52	2.44	1.40	1.05
Fibroblast - Dermal, donor6	11458-119A9	8.77	13.64	0.97	0.49	2.76	1.14	0.49
Fibroblast - Gingival, donor1	11237-116D4	5.00	10.00	0.83	0.00	2.08	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.29	20.70	2.62	0.26	1.05	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	11.60	11.99	1.05	0.53	4.09	1.84	1.45
Fibroblast - Gingival, donor3	11394-118C8	18.37	24.95	3.87	0.29	3.67	1.55	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	7.27	1.04	0.00	2.08	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.63	8.99	0.35	0.18	2.47	1.59	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.19	21.83	1.87	0.16	2.96	1.25	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.44	13.52	1.62	0.14	2.84	0.68	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.82	21.88	2.82	0.00	1.06	1.06	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	7.02	11.26	1.61	0.29	2.49	0.73	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.36	15.95	2.05	0.27	3.27	1.50	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	20.29	17.99	1.32	0.11	2.63	1.43	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	7.63	16.43	1.32	0.59	2.93	1.17	0.15
Fibroblast - Lung, donor1	11270-116H1	2.72	6.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	2.98	10.45	1.49	0.00	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	8.02	11.40	2.11	0.21	2.53	0.84	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	27.49	48.32	4.17	0.00	3.33	2.50	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	13.99	1.40	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.47	9.24	1.40	0.00	4.48	1.96	0.28
Fibroblast - Mammary, donor1	11540-120B1	32.48	38.16	6.50	0.41	3.25	1.62	0.41
Fibroblast - Mammary, donor2	11620-122A9	11.98	23.97	0.00	0.00	11.98	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00	0.00	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	7.95	12.22	2.52	0.00	1.16	0.97	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	12.13	18.20	2.28	0.61	4.55	2.88	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.36	21.42	3.37	0.00	1.22	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.07	10.30	2.29	0.00	3.05	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.83	6.21	1.08	0.27	2.43	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.90	11.71	1.28	0.35	0.70	1.39	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.53	4.42	0.22	0.11	1.99	0.33	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	30.07	27.43	3.86	0.41	4.06	1.83	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.74	14.03	0.67	0.00	3.34	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.12	5.93	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	8.73	9.72	1.59	0.40	4.17	2.78	1.98
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	7.82	8.70	0.18	0.18	1.78	2.13	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.88	9.85	1.18	0.00	1.97	2.17	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	3.91	4.21	1.20	0.00	1.50	1.81	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	6.48	6.05	2.70	0.22	3.24	2.48	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.36	6.07	0.76	0.25	1.52	1.77	0.25
Fibroblast - skin normal, donor1	11553-120C5	7.88	8.37	0.66	0.00	1.31	1.15	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	10.03	11.83	0.80	0.20	0.80	0.80	0.40
Fibroblast - skin normal, donor2	11561-120D4	6.33	7.74	1.31	0.30	3.01	1.91	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	5.74	10.28	1.21	0.00	2.12	1.81	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	14.83	13.17	0.83	0.17	2.24	1.08	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	5.98	8.72	1.37	0.51	2.74	1.71	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.21	5.58	0.66	0.00	0.66	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8.84	6.07	0.96	0.32	1.38	2.13	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	11.30	8.27	0.84	0.17	2.19	1.52	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.90	5.80	1.25	0.16	2.98	3.14	1.73
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	22.16	0.00	66.48	88.64	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	24.40	13.94	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.45	4.33	0.87	0.00	0.35	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	5.73	8.07	1.30	0.78	0.52	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.75	8.18	1.02	0.00	0.77	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	35.98	13.78	1.53	0.00	2.30	1.53	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	24.88	12.76	0.64	0.00	1.91	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	24.82	20.54	1.43	0.29	2.85	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	16.82	21.23	1.10	0.00	4.14	1.10	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	27.63	19.18	0.46	0.00	3.88	2.51	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	18.62	16.64	2.18	0.20	2.58	0.99	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.80	17.97	0.53	0.53	4.23	1.32	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.07	17.29	1.30	0.00	2.28	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	14.59	13.27	0.88	0.00	3.10	1.33	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	13.57	16.82	1.41	0.42	3.82	2.54	2.83
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.20	21.06	0.49	0.37	4.31	3.82	2.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.73	16.39	1.61	0.81	4.30	1.61	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.55	17.72	0.99	0.99	2.85	2.23	2.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	22.70	21.59	1.38	0.83	4.84	3.32	3.18
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.09	16.87	0.81	0.81	4.88	3.86	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.52	16.66	0.46	0.23	2.51	1.14	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.94	15.82	1.25	0.87	6.35	1.87	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.92	26.01	2.40	0.66	3.72	1.53	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	17.73	11.23	0.59	0.59	2.66	0.59	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.44	15.58	0.95	0.79	5.40	3.34	3.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.64	18.54	0.67	0.67	1.56	0.45	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.56	15.12	0.60	1.01	3.43	2.22	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	24.09	15.27	1.02	0.85	5.09	2.54	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	25.63	18.27	1.42	0.53	3.46	1.33	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.62	24.14	0.73	0.42	2.29	1.04	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.15	14.35	1.02	0.34	1.88	0.34	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.35	16.49	0.77	0.55	3.21	2.32	2.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.39	13.15	0.50	0.17	2.41	1.08	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.74	11.84	0.41	0.41	2.25	1.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.47	17.33	0.62	0.83	4.13	0.83	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.41	15.68	0.81	0.35	3.92	2.42	2.42
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.34	16.68	0.83	0.17	3.00	2.00	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.75	14.99	0.66	0.66	2.65	1.76	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.05	15.50	0.98	0.12	6.76	3.81	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	24.64	16.70	1.62	0.32	4.05	2.27	2.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.00	15.72	0.64	0.00	3.53	2.89	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	13.83	11.18	0.19	0.38	4.17	1.80	1.71
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	14.24	14.71	1.42	0.16	1.90	0.95	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.12	12.47	0.91	0.30	3.34	2.74	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	17.56	11.39	0.42	0.42	2.40	1.15	2.40
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	12.95	13.17	0.88	0.44	2.85	0.88	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	18.52	14.59	1.40	0.84	4.21	2.24	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	15.46	7.87	1.39	0.28	1.20	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.51	10.16	0.00	0.27	2.94	0.80	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	16.68	13.01	1.99	0.15	1.53	2.14	1.84
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.60	7.38	1.04	0.00	1.17	1.30	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	12.20	10.84	1.08	0.27	3.80	2.44	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.30	13.27	0.92	0.55	4.79	1.29	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.45	11.84	1.10	0.22	3.73	1.75	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	33.72	43.64	6.94	0.00	5.95	6.94	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.51	11.48	1.19	0.26	3.43	1.32	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.31	11.90	0.61	0.40	1.82	1.82	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	58.97	55.66	3.30	0.25	2.29	1.02	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.52	13.34	0.80	0.80	3.98	1.99	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	19.88	23.88	2.00	0.00	5.55	3.70	2.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	30.28	24.35	1.43	1.43	6.14	3.68	2.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.71	14.71	1.25	0.00	1.25	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.02	4.52	0.00	0.00	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	31.36	20.75	2.31	0.00	1.84	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	12.37	2.47	0.00	12.37	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	35.59	15.86	1.16	0.00	2.32	2.32	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	11.23	1.60	0.00	0.00	3.21	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	15.65	0.00	0.00	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	25.39	16.27	0.33	0.33	3.58	3.25	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	27.59	18.12	0.41	0.00	6.18	2.47	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	19.99	3.33	3.33	19.99	23.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	24.61	12.30	1.12	0.56	3.92	1.12	2.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	23.86	17.32	1.63	0.98	2.94	4.25	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	20.97	20.97	1.68	0.84	7.55	6.71	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	27.67	19.40	2.54	0.64	4.45	2.86	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.68	19.70	1.36	0.34	2.72	2.38	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	14.62	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.91	20.04	0.57	1.15	5.15	2.29	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.09	13.02	0.89	0.30	5.33	2.07	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	6.78	1.69	0.00	11.86	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	27.34	16.15	2.07	0.00	6.63	1.66	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	24.85	16.57	0.92	0.00	3.68	2.53	2.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	15.81	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.53	9.61	1.15	0.38	3.84	1.15	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.76	14.02	1.30	0.33	2.28	1.30	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	9.36	7.36	0.67	0.00	0.67	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.88	22.73	1.16	0.77	5.39	2.31	6.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	59.22	22.94	2.40	1.37	5.48	3.42	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	34.79	0.00	0.00	19.88	2.48	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	14.63	21.71	2.36	0.00	4.72	3.77	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.29	12.07	1.21	0.00	3.62	3.02	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.28	13.23	0.00	0.00	2.54	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	18.75	18.75	0.80	0.00	5.98	2.39	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	16.28	13.32	0.49	0.49	5.92	4.44	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	23.61	3.54	0.00	3.54	4.72	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.25	23.34	0.58	0.00	3.50	2.92	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.97	18.43	1.76	0.44	5.27	2.63	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	37.30	18.65	0.85	0.00	2.54	4.24	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	18.50	10.15	1.19	0.60	2.39	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.53	13.10	1.94	0.00	5.34	0.49	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	12.55	2.28	0.00	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	13.72	1.25	0.42	1.66	2.08	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	14.62	3.37	0.00	4.50	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	10.78	0.63	0.00	4.76	2.54	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	1.67	3.34	0.42	0.00	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	5.34	6.61	0.81	0.12	3.13	1.28	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	6.58	8.27	1.69	0.34	5.06	2.53	2.03
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.32	7.74	2.28	0.23	4.55	2.73	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.79	4.81	1.20	0.22	4.37	2.73	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.16	7.52	1.07	0.43	3.87	3.65	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	5.17	6.24	1.08	0.43	3.23	1.94	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	6.23	4.48	1.25	0.00	2.37	0.87	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.00	4.29	2.40	0.17	2.23	1.54	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.84	5.13	0.00	0.00	2.56	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.39	15.67	1.12	0.00	2.24	2.80	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.42	16.01	4.33	0.00	4.76	1.73	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	13.22	0.00	0.00	7.93	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.35	15.87	2.47	0.35	2.12	1.76	2.82
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.90	10.90	2.18	0.00	4.36	1.45	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.39	6.47	1.05	0.00	1.75	2.10	1.05
Hepatocyte, donor1	11523-119I2	30.27	8.47	1.21	0.00	2.42	1.21	3.63
Hepatocyte, donor2	11603-120I1	26.93	9.70	2.15	0.00	3.23	2.15	1.08
Hepatocyte, donor3	11684-122I1	15.95	15.34	1.23	0.00	2.45	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	40.47	19.58	1.31	1.31	1.31	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.64	21.50	1.57	0.35	3.85	3.67	2.62
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.39	6.17	0.69	0.14	1.37	0.82	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	6.37	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	8.31	1.38	0.00	4.15	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	22.52	0.00	0.00	2.50	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	35.60	0.00	0.00	11.87	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	12.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	24.36	3.25	1.62	3.25	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	13.34	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	11.91	15.88	0.00	1.32	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	14.41	0.00	0.00	2.22	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	10.48	0.00	0.00	0.00	0.00	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.08	13.86	1.26	1.26	2.52	0.00	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	15.47	1.55	0.00	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	21.97	16.15	0.00	0.65	1.94	3.88	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	19.32	0.00	0.00	3.22	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	23.63	20.37	3.26	0.81	1.63	1.63	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	21.41	14.69	0.84	0.42	2.52	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	21.70	12.06	0.80	0.80	2.41	0.00	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	13.85	10.16	3.69	0.92	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	12.75	1.89	0.94	1.42	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	13.60	3.63	0.00	0.91	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	18.29	1.08	1.08	3.23	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	25.41	0.00	0.00	3.81	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.68	12.75	0.64	0.64	2.55	3.19	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	12.76	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	12.85	1.43	0.00	2.14	2.86	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	15.43	10.49	0.93	0.00	2.16	1.85	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	22.83	1.76	1.76	0.00	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	12.57	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	13.21	0.00	0.00	4.87	4.17	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	11.07	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	12.97	3.24	0.00	0.00	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	22.67	22.67	1.74	0.87	1.74	2.62	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	13.50	4.50	0.00	2.25	4.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	17.42	3.48	0.00	6.97	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	29.87	17.07	2.13	1.07	5.33	3.20	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	16.63	0.00	1.39	1.39	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	11.40	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	23.01	0.92	0.00	2.76	2.76	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	27.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	6.21	0.00	0.00	0.00	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	25.38	16.92	0.00	1.06	3.17	2.11	4.23
Keratinocyte - epidermal, donor1	11272-116H3	13.22	9.30	0.24	0.00	2.77	1.55	1.06
Keratinocyte - epidermal, donor2	11349-117G8	16.40	10.54	0.59	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.75	14.20	1.42	0.38	3.69	1.33	1.33
Keratinocyte - oral, donor1	11251-116E9	11.01	17.03	1.82	0.91	6.58	4.77	4.09
Keratocytes, donor1	11527-119I6	60.17	48.48	3.78	0.69	5.16	4.81	2.41
Keratocytes, donor2	11607-120I5	10.55	18.75	2.34	0.00	4.69	1.17	1.17
Keratocytes, donor3	11688-122I5	16.99	17.78	2.37	0.59	3.36	0.59	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	65.94	32.97	4.40	0.00	0.00	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	8.63	5.39	0.00	0.00	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	4.96	4.84	1.38	0.12	1.27	0.46	0.58
Lens Epithelial Cells, donor3	11690-122I7	16.95	14.13	2.42	0.30	1.11	0.81	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.64	10.79	1.78	0.36	2.73	0.95	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	7.81	0.28	0.28	1.95	1.40	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.33	9.92	1.10	0.16	3.31	0.79	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.38	3.23	0.54	0.00	3.76	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.36	6.30	0.32	0.32	3.47	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.73	8.73	0.54	0.43	4.20	1.40	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.57	7.80	0.41	0.00	2.05	1.64	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.06	6.07	0.51	0.25	2.02	0.51	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.12	10.42	0.99	0.28	4.22	1.27	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.52	8.31	1.19	0.00	2.37	0.79	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.79	6.01	0.78	0.00	1.55	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.37	5.55	0.56	0.00	1.67	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.57	6.62	0.35	0.35	2.09	0.70	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.58	6.92	0.48	0.24	1.19	0.95	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.83	8.10	0.41	0.69	3.16	1.10	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.55	7.70	0.62	1.23	3.08	0.62	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.30	2.81	0.00	0.31	1.25	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.89	10.98	1.10	0.00	4.03	0.73	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.25	10.20	0.33	0.33	3.29	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.44	7.32	0.29	0.00	2.93	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.96	9.21	1.24	0.00	4.23	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.82	5.33	0.00	0.48	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.39	8.08	0.27	0.27	2.15	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.33	8.48	0.91	0.15	3.78	0.91	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	7.78	0.52	0.00	2.59	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.49	8.38	0.42	0.21	1.05	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.97	10.07	1.20	0.15	2.56	1.35	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	2.75	0.00	0.69	2.75	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.20	6.40	0.19	0.19	2.63	0.94	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.27	9.01	1.17	0.11	3.71	1.06	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	8.24	0.97	0.00	5.33	1.45	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.95	6.62	0.33	0.00	2.65	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.67	8.05	0.62	0.12	4.21	1.73	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.92	7.03	1.48	0.00	2.59	0.74	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.20	4.20	0.99	0.00	0.49	0.49	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.84	6.87	0.00	0.27	2.47	0.41	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.43	9.97	0.64	0.32	1.61	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.78	8.52	0.30	0.00	1.83	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.58	7.00	1.40	0.28	3.22	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.27	8.53	0.71	0.00	1.78	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	4.36	0.48	0.00	0.97	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.76	9.18	0.31	0.31	4.98	1.87	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	5.37	1.07	0.00	1.79	1.79	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.25	6.86	0.00	0.00	2.61	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.06	7.30	0.00	0.24	2.59	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.91	10.89	1.49	0.00	2.97	1.11	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.87	5.12	0.51	0.00	1.28	0.51	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.27	10.44	0.90	0.30	2.39	0.60	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	6.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	18.41	21.48	0.00	1.53	2.30	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	4.45	0.00	0.00	3.71	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	26.23	20.73	1.27	1.69	4.23	2.96	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	6.33	0.70	0.00	3.52	2.11	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	6.54	0.93	0.00	1.87	1.87	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	21.13	15.97	0.00	0.00	6.18	4.64	4.12
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	10.71	0.00	0.00	2.38	1.19	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.96	7.69	0.23	0.23	0.68	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	14.83	10.18	0.58	0.00	3.78	2.91	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	13.06	11.25	0.90	0.45	2.70	3.60	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.39	15.45	0.41	0.27	2.44	1.35	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	23.11	11.30	0.00	0.51	2.57	2.57	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	18.35	13.76	0.35	0.00	2.47	3.18	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	8.66	0.00	0.67	0.67	2.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	8.15	0.00	0.51	3.57	3.06	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.08	10.41	0.80	0.80	2.67	2.93	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	26.64	17.38	0.76	0.94	2.46	2.46	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	12.88	0.00	0.00	7.36	1.23	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	35.06	16.31	1.63	0.82	5.71	0.00	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	23.95	19.57	0.83	0.42	3.75	4.16	3.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.34	10.37	0.00	0.00	3.92	2.24	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	17.52	2.06	1.03	2.06	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	27.29	18.87	0.87	1.16	5.52	5.23	4.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.43	10.16	0.00	0.00	2.69	1.20	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.60	9.41	0.00	0.00	4.43	2.21	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	35.00	27.93	0.71	0.71	6.72	7.42	5.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.40	13.64	0.00	0.37	4.06	2.95	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	9.21	0.00	0.00	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	26.10	21.87	1.15	0.00	3.07	4.99	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.27	15.29	0.57	0.00	7.36	7.36	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	8.20	0.00	0.82	2.46	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.73	23.05	1.81	0.90	5.87	3.16	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	21.54	12.21	0.00	0.00	2.87	4.31	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.15	15.68	0.75	0.00	2.99	2.99	5.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.81	24.90	1.49	0.74	10.40	6.32	7.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.66	15.08	0.86	0.00	3.88	2.58	3.45
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	17.98	1.71	0.00	2.57	8.56	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	26.65	24.99	0.33	0.33	10.00	5.66	5.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.91	19.31	0.00	0.60	1.21	3.62	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.93	14.93	2.13	0.00	0.71	2.13	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.37	21.31	1.72	1.37	4.81	4.81	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.25	14.49	0.00	0.00	5.90	4.29	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	17.51	0.67	0.67	2.69	2.69	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.37	28.15	0.37	0.37	7.41	5.19	5.19
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	9.30	0.00	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	19.04	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	23.21	23.21	2.80	1.20	3.20	2.80	4.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	22.53	10.90	1.45	0.00	2.91	2.18	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	25.30	16.10	2.30	0.00	0.77	2.30	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.61	24.17	0.49	0.49	3.45	5.43	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	21.64	6.59	0.00	0.00	6.59	1.88	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.60	14.58	0.00	0.50	3.02	1.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	31.54	23.43	2.25	0.90	7.21	2.70	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	15.49	0.00	1.72	5.16	8.61	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.50	21.82	0.45	1.34	3.12	4.45	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	27.37	29.72	1.17	1.17	5.47	4.69	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.77	11.88	0.66	0.66	3.30	1.98	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.54	19.72	2.59	0.00	1.56	0.52	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.32	31.50	0.00	0.44	7.88	7.88	6.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	12.86	0.00	0.56	2.24	1.68	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.06	22.97	0.00	0.44	0.88	0.88	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	32.40	23.14	0.77	0.77	6.17	2.31	3.86
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	21.77	16.20	0.51	0.00	4.05	5.06	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.11	15.38	0.48	0.48	4.33	2.88	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.44	20.67	1.59	0.00	4.77	3.58	5.17
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.23	11.54	0.00	0.00	4.25	3.04	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.29	11.76	0.69	0.00	1.38	4.15	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	27.74	29.26	2.66	1.52	3.04	5.32	4.56
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	24.79	10.33	1.03	0.52	3.10	5.16	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.37	6.05	0.00	0.60	2.42	3.63	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	29.79	24.40	0.00	1.27	4.12	2.22	4.44
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.72	13.86	0.53	0.53	4.26	5.33	4.26
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.37	11.49	0.57	0.00	1.72	1.15	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	41.65	31.37	1.54	2.06	4.11	6.69	5.14
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	19.81	0.71	0.71	3.54	6.37	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	30.64	13.05	1.13	0.57	6.24	5.67	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	33.70	29.12	1.25	2.08	4.58	2.08	6.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	29.76	22.71	0.00	0.78	9.40	5.48	7.05
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.20	10.02	0.00	1.25	4.59	2.92	3.34
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	33.92	26.48	0.46	1.39	5.58	6.04	6.97
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.08	15.39	0.00	0.67	2.01	5.35	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.06	15.50	0.00	0.00	3.21	2.14	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.18	32.33	1.62	0.00	7.68	7.27	6.87
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	15.60	0.00	0.00	3.67	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	11.56	0.89	0.89	5.33	0.89	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	38.75	26.21	0.00	1.71	7.98	4.56	5.70
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	16.87	0.00	0.77	1.53	2.30	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	12.59	0.55	0.55	5.47	6.02	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	33.41	32.52	0.45	1.34	9.80	4.90	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	31.97	19.76	0.26	0.78	4.16	1.56	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	9.95	1.99	1.33	2.65	7.29	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	10.39	0.00	0.00	4.16	4.16	12.47
Macrophage - monocyte derived, donor1	11232-116C8	6.84	10.71	0.23	0.00	0.91	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	7.52	6.61	0.00	0.18	0.18	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	6.69	9.44	0.66	0.39	0.66	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1.59	2.12	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	4.60	3.33	0.48	0.16	1.90	1.11	1.43
Mallassez-derived cells, donor3	11930-125I4	5.56	4.86	0.28	0.00	2.22	0.83	0.56
Mammary Epithelial Cell, donor1	11273-116H4	11.66	12.16	1.49	0.40	4.68	2.39	1.79
Mammary Epithelial Cell, donor2	11350-117G9	8.40	6.37	0.58	0.00	3.76	3.19	1.74
Mammary Epithelial Cell, donor3	11422-118F9	11.47	11.72	2.00	0.75	2.24	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	134.91	79.32	6.10	1.36	30.51	2.03	4.75
Mast cell, donor1	11563-120D6	17.63	26.39	1.30	0.00	1.73	1.19	1.41
Mast cell, donor2	11565-120D8	18.72	58.25	1.78	0.30	2.97	1.19	0.59
Mast cell, donor3	11566-120D9	31.74	59.88	3.38	0.00	4.50	0.45	0.90
Mast cell, donor4	11567-120E1	25.71	61.52	1.60	0.53	5.14	0.71	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	11.87	21.40	0.67	0.44	3.44	1.55	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	19.85	13.42	0.58	0.00	2.33	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	7.23	13.54	0.34	0.34	2.06	0.23	0.11
Mast cell, expanded, donor8	11941-126A6	13.05	25.61	0.67	0.17	2.85	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	5.67	6.37	0.50	0.20	0.80	0.70	0.60
Melanocyte - dark, donor2	11582-120F7	6.92	5.19	1.38	0.69	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	12.10	9.63	1.09	0.29	2.39	1.38	1.67
Melanocyte - light, donor1	11274-116H5	11.28	12.93	0.24	0.00	3.06	1.88	0.47
Melanocyte - light, donor2	11351-117H1	5.46	7.51	0.68	0.00	1.36	0.68	0.00
Melanocyte - light, donor3	11423-118G1	13.01	8.67	0.87	0.87	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	13.02	7.81	1.35	0.10	2.29	1.77	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	5.65	5.92	0.54	0.00	3.50	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	11.79	9.11	2.41	0.00	3.21	2.14	1.34
Meningeal Cells, donor1	11493-119E8	24.56	21.21	2.23	0.25	3.85	1.74	0.50
Meningeal Cells, donor2	11573-120E7	18.49	16.29	0.88	0.44	0.44	1.32	0.44
Meningeal Cells, donor3	11654-122E7	18.01	11.49	0.98	0.33	5.79	2.77	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	3.71	5.99	0.86	0.00	0.86	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.47	6.14	0.60	0.10	0.50	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	28.91	3.94	0.00	7.88	3.94	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	14.39	2.62	0.00	6.54	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	6.46	4.31	1.44	0.00	3.59	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.44	7.62	1.69	0.00	1.91	1.06	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.03	7.04	0.50	0.00	2.01	4.02	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.48	13.62	0.88	0.22	4.83	1.98	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	15.34	12.42	0.73	0.73	5.84	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.77	10.03	1.64	0.20	4.50	0.82	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.35	2.91	0.00	0.14	1.25	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.27	9.29	0.74	0.74	2.23	2.23	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.03	11.58	1.45	0.26	4.74	1.18	1.84
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.39	14.24	2.97	0.30	3.56	1.78	2.67
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	18.68	0.00	0.00	11.68	0.00	9.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	10.25	3.20	0.00	2.56	0.64	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	2.48	4.25	1.06	0.00	1.42	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	3.13	7.51	0.31	0.63	1.56	0.31	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.18	2.18	0.00	0.00	0.73	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	5.04	5.83	0.80	0.00	1.33	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	5.51	6.01	0.50	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	9.68	12.14	1.23	0.14	1.23	1.52	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	36.46	58.06	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.36	12.07	0.25	0.00	0.74	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.42	12.96	0.88	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	41.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.51	8.99	0.62	0.00	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.88	5.60	0.00	0.21	1.24	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	30.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.01	8.76	0.25	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	15.36	0.00	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.28	6.71	0.41	0.00	1.02	0.81	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	6.34	0.00	0.00	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	51.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	6.19	0.00	0.00	0.88	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	4.56	0.00	0.00	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	17.11	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.46	6.58	0.00	0.21	0.21	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	21.18	17.50	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.38	8.94	0.30	0.30	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	16.77	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.52	5.27	0.00	0.00	0.75	0.75	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.65	6.89	0.71	0.24	1.19	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	13.82	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.30	7.37	0.00	0.00	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.10	7.78	0.00	0.00	0.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.95	8.97	0.20	0.00	0.41	0.61	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.29	3.65	0.00	0.21	0.43	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.56	7.56	0.00	0.00	0.67	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	41.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.69	5.48	0.44	0.00	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	12.17	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	18.23	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.88	7.34	0.00	0.54	0.54	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.82	6.47	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	21.81	0.00	0.00	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.36	3.84	0.00	0.00	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	4.80	0.00	0.80	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	28.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.50	3.50	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	16.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.19	6.13	0.00	0.00	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	16.55	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	15.37	19.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.21	5.70	0.25	0.00	0.74	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	14.61	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	26.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.76	5.13	0.00	0.00	0.68	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	9.63	16.63	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.75	16.33	0.71	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	3.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	13.72	0.00	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	21.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.64	5.43	0.60	0.30	0.90	1.51	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.84	7.51	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	28.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	8.31	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	4.55	9.11	0.57	0.57	1.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.40	13.68	0.55	0.14	0.41	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.11	5.18	0.26	0.00	0.52	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.29	12.44	0.43	0.00	0.43	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.24	18.42	3.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.21	8.01	0.27	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.99	14.37	0.30	0.30	0.90	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.79	10.88	0.42	0.28	0.99	0.71	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.78	1.91	0.32	0.00	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.31	11.94	0.22	0.22	1.11	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	16.31	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.11	4.55	0.57	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.39	7.37	0.74	0.00	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	25.42	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.35	6.17	0.88	0.00	0.88	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.21	10.09	0.58	0.29	0.86	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.01	16.90	0.00	0.00	2.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.74	11.32	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	3.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.94	6.90	0.33	0.00	0.99	4.60	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	2.10	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.94	7.12	0.20	0.20	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	3.73	9.31	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	3.76	4.88	0.75	0.00	1.13	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.46	3.73	0.27	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.17	4.30	0.11	0.00	0.45	0.34	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	5.89	1.47	0.00	4.42	3.68	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2.56	4.03	0.00	0.00	1.47	2.20	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	10.89	1.56	0.00	3.11	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	0.53	1.07	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	3.03	0.00	1.01	7.07	4.04	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.22	3.79	0.00	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	3.24	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	3.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	28.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	9.79	0.00	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.67	8.83	0.43	0.22	2.80	1.94	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	16.72	1.05	0.00	3.66	3.14	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	5.34	0.67	0.67	2.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	15.03	1.67	0.00	0.83	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	4.94	6.08	3.23	0.19	2.28	0.57	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	38.30	14.36	0.00	0.00	1.60	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3.40	4.08	2.04	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	5.51	1.84	0.00	1.84	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	3.77	0.42	0.00	1.26	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.18	6.04	0.93	0.23	0.46	1.39	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.03	6.22	1.35	0.27	1.89	0.81	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.19	11.56	1.47	0.00	0.84	1.05	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	11.13	0.00	0.00	55.67	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.46	2.98	0.00	0.00	1.49	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	3.25	3.79	1.08	0.27	1.35	1.35	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.21	3.40	0.23	0.23	1.13	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.86	6.04	0.16	0.00	0.65	0.65	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.20	9.30	2.00	0.36	1.82	1.28	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.96	1.06	0.53	0.00	1.59	2.12	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	4.80	0.00	0.60	1.80	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.19	5.91	3.28	0.00	3.28	1.97	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.07	3.90	0.33	0.00	1.14	0.65	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.87	20.46	1.94	0.00	3.70	1.23	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	2.81	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.06	5.98	0.92	0.00	2.30	0.00	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.75	5.46	0.64	0.00	0.64	1.29	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.24	7.59	1.72	0.69	4.83	3.79	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	42.98	7.59	5.06	30.34	22.76	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	15.59	18.05	2.67	0.22	1.78	1.11	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.16	4.23	0.85	0.00	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.22	5.46	0.47	0.47	0.71	0.71	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	4.72	0.43	0.00	2.15	1.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	9.03	99.31	36.11	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	7.00	1.00	0.00	1.67	1.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.40	19.39	1.80	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.14	2.78	0.40	0.00	1.59	1.19	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	5.57	1.86	0.00	1.86	0.00	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.05	4.16	1.14	0.00	1.14	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.08	6.84	0.33	0.00	1.30	2.61	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.20	10.02	0.00	0.00	0.44	0.87	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	21.26	0.45	0.00	1.81	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	3.53	0.88	0.00	3.53	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.98	2.66	0.66	0.00	1.33	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	6.94	3.47	0.50	0.00	0.99	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.10	3.45	1.15	0.38	1.91	0.77	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.44	7.56	0.30	0.30	2.12	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	14.37	11.49	0.00	0.66	1.11	1.11	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	4.74	0.00	0.00	1.36	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	20.44	5.11	0.00	5.11	5.11	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.66	5.49	0.00	0.00	0.61	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.44	6.92	1.26	0.00	0.00	0.31	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.01	8.78	0.61	0.00	0.61	1.21	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.16	2.37	0.00	0.00	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	15.87	1.13	1.13	2.27	3.40	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	15.17	0.00	0.00	10.12	0.00	5.06
Myoblast, donor1	11241-116D8	5.34	4.84	0.37	0.00	1.24	0.12	0.12
Myoblast, donor2	11322-117D8	11.51	7.67	0.96	0.58	2.88	1.34	0.19
Myoblast, donor3	11398-118D3	6.89	11.44	1.85	0.17	0.84	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.79	18.97	0.88	1.02	4.38	3.79	1.75
Natural Killer Cells, donor1	11230-116C6	52.89	28.60	0.92	0.62	5.23	3.38	3.38
Natural Killer Cells, donor2	11311-117C6	53.68	27.14	1.21	0.30	5.73	3.92	1.21
Natural Killer Cells, donor3	11387-118C1	64.97	33.68	1.66	0.55	3.31	2.21	2.76
Neural stem cells, donor1	11275-116H6	90.01	33.03	0.73	0.73	3.63	0.36	1.45
Neural stem cells, donor2	11352-117H2	82.80	40.44	3.85	0.00	0.00	3.85	3.85
Neurons, donor1	11494-119E9	35.27	22.76	1.14	1.14	4.55	3.41	1.14
Neurons, donor2	11574-120E8	14.31	9.25	0.00	0.00	2.64	1.32	0.22
Neurons, donor3	11655-122E8	18.91	12.33	0.00	0.00	4.11	1.64	2.47
Neutrophils, donor1	11233-116C9	139.20	91.87	2.78	1.86	14.85	10.21	11.14
Neutrophils, donor2	11314-117C9	92.76	81.17	2.90	0.00	31.89	34.79	8.70
Neutrophils, donor3	11390-118C4	112.40	134.39	7.33	1.83	10.38	2.44	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	11.40	14.01	1.54	0.59	7.84	3.68	3.44
Nucleus Pulposus Cell, donor2	11409-118E5	9.77	7.81	0.33	0.00	2.60	0.98	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	3.01	4.81	0.40	0.00	1.40	1.40	0.80
Olfactory epithelial cells, donor1	11933-125I7	15.83	10.87	1.79	0.69	5.09	2.62	2.62
Olfactory epithelial cells, donor2	11934-125I8	11.00	11.58	1.16	0.14	8.40	3.76	1.88
Olfactory epithelial cells, donor3	11935-125I9	11.46	11.01	1.25	0.11	4.43	1.14	0.57
Olfactory epithelial cells, donor4	11936-126A1	13.83	18.99	0.78	0.39	3.12	1.17	2.43
Oligodendrocyte - precursors, donor1	11496-119F2	6.02	10.83	1.81	0.00	1.81	1.81	1.20
Osteoblast - differentiated, donor1	11276-116H7	10.00	5.32	0.64	0.43	1.06	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	12.57	0.00	0.00	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	3.10	10.55	1.24	0.00	0.00	0.62	0.62
Osteoblast, donor1	11277-116H8	21.69	16.22	0.98	0.20	1.95	0.78	0.00
Osteoblast, donor2	11354-117H4	16.86	18.26	1.40	0.00	2.81	2.81	0.00
Osteoblast, donor3	11426-118G4	13.69	17.42	1.24	0.36	1.07	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	9.18	9.86	1.35	0.08	4.38	1.77	1.94
Pericytes, donor1	11491-119E6	13.69	12.13	1.56	0.33	3.67	2.78	1.11
Pericytes, donor2	11571-120E5	9.28	9.05	1.36	0.23	4.75	2.49	1.58
Pericytes, donor3	11652-122E5	15.06	8.54	1.63	0.81	3.87	2.24	1.02
Perineurial Cells, donor1	11499-119F5	8.82	10.17	0.90	0.11	1.58	1.02	1.02
Perineurial Cells, donor2	11579-120F4	7.08	7.27	1.66	0.09	1.20	0.37	1.38
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	32.83	37.93	1.59	0.96	7.97	3.51	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.69	27.91	0.98	0.24	7.35	2.94	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	29.77	28.08	2.72	0.78	5.56	2.33	1.16
Placental Epithelial Cells, donor1	11278-116H9	11.48	10.28	0.00	0.24	0.72	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	2.22	6.65	0.00	0.00	2.22	3.33	1.11
Placental Epithelial Cells, donor3	11427-118G5	9.03	15.90	0.59	0.59	1.96	1.37	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.01	5.06	0.00	0.00	1.90	1.27	1.27
Preadipocyte - breast, donor1	11467-119B9	14.07	3.94	0.19	0.00	0.56	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.75	8.48	0.52	0.13	0.65	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	12.16	8.11	0.23	0.45	2.25	0.68	0.45
Preadipocyte - omental, donor1	11468-119C1	11.08	7.46	0.96	0.00	1.60	0.85	0.53
Preadipocyte - omental, donor2	11329-117E6	7.86	6.11	0.87	0.00	0.44	1.31	1.31
Preadipocyte - omental, donor3	11403-118D8	17.33	14.18	1.43	0.29	2.01	2.15	1.43
Preadipocyte - perirenal, donor1	11469-119C2	1.97	2.95	0.00	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.51	12.59	2.15	0.31	1.23	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	14.17	15.23	1.24	0.53	4.60	3.72	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	11.41	6.98	0.51	0.34	1.53	0.68	0.17
Preadipocyte - visceral, donor1	11280-116I2	12.76	12.02	0.75	0.09	2.24	0.84	0.47
Preadipocyte - visceral, donor2	11357-117H7	5.52	11.96	1.38	0.92	4.14	1.84	1.38
Preadipocyte - visceral, donor3	11429-118G7	5.12	7.00	0.52	0.31	1.36	0.42	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	34.09	17.95	0.91	0.60	6.03	2.26	1.81
Prostate Epithelial Cells, donor2	11331-117E8	7.72	5.82	0.27	0.14	1.90	1.76	1.22
Prostate Epithelial Cells, donor3	11404-118D9	14.21	14.08	1.96	0.55	4.47	3.31	1.35
Prostate Stromal Cells, donor1	11254-116F3	10.25	9.68	1.59	0.23	3.87	1.25	0.57
Prostate Stromal Cells, donor2	11332-117E9	13.09	10.94	0.72	1.08	4.30	2.87	2.33
Prostate Stromal Cells, donor3	11405-118E1	7.72	8.03	1.15	0.42	3.34	1.67	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	19.71	17.15	1.82	0.00	1.09	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.79	5.27	0.42	0.42	2.98	0.90	0.97
Renal Epithelial Cells, donor1	11517-119H5	20.80	21.30	0.00	1.01	3.04	3.04	1.52
Renal Epithelial Cells, donor2	11597-120H4	7.82	13.52	2.85	0.71	2.13	1.42	2.13
Renal Epithelial Cells, donor3	11678-122H4	7.62	8.68	0.74	0.21	4.23	1.48	2.12
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	10.21	0.68	0.00	2.72	3.40	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.14	11.05	0.81	0.27	2.56	1.21	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.10	12.88	4.22	0.00	3.33	4.22	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	25.29	15.97	0.00	0.00	5.32	2.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	14.97	16.07	1.32	0.22	2.86	1.54	1.32
Renal Mesangial Cells, donor2	11598-120H5	20.06	10.03	1.25	0.00	1.25	1.88	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.04	15.81	2.50	0.55	3.33	1.11	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	20.67	12.62	0.27	0.27	3.76	3.49	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	14.34	10.96	0.84	0.00	2.53	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.13	15.43	1.93	0.58	6.17	2.89	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2.85	4.67	0.26	0.00	3.11	0.52	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	17.91	13.64	0.85	0.28	3.41	2.84	2.27
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	6.17	1.03	0.00	3.09	1.03	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	11.29	4.52	0.00	0.25	2.76	2.01	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	22.18	25.66	2.67	0.13	6.41	0.80	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	14.29	14.29	0.00	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.86	12.66	0.00	0.00	14.86	1.65	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	32.48	26.68	0.58	0.00	4.06	1.74	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.99	12.09	0.13	0.26	2.34	1.56	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	22.44	13.51	0.40	0.40	3.87	2.38	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	24.65	11.82	0.56	0.22	2.34	0.33	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	13.89	12.53	0.87	0.62	5.95	2.85	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.65	14.68	0.58	0.35	3.61	2.33	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.43	24.27	0.92	0.23	8.09	2.77	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.77	8.35	0.14	0.27	2.33	1.64	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.42	10.29	0.45	0.15	4.39	1.82	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.68	13.62	0.00	0.36	0.54	0.72	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.05	7.32	0.14	0.43	4.02	0.86	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.49	12.02	0.43	0.32	5.04	2.25	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	20.14	13.94	0.00	0.00	3.32	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.24	7.26	0.76	0.38	3.82	1.15	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.82	16.49	0.19	0.37	2.89	1.68	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	30.82	20.48	0.19	0.38	4.51	1.88	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.86	13.80	0.40	0.00	1.73	1.19	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.70	16.65	0.39	0.68	4.96	3.11	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.25	21.20	0.95	0.00	5.16	1.15	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.03	8.97	0.53	0.32	2.99	1.07	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.30	17.66	0.28	0.56	3.64	3.92	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	26.49	20.34	0.00	0.34	4.27	0.85	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.94	10.03	0.18	0.36	0.91	0.55	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.93	14.72	0.37	0.49	5.03	2.33	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.31	15.98	0.40	0.27	4.30	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	11.32	7.08	0.71	0.47	6.13	2.12	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.23	15.48	0.60	0.20	3.57	1.98	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.36	15.67	0.23	0.00	3.27	0.70	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	13.69	7.67	0.21	0.00	2.49	2.49	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.78	12.39	0.00	0.22	7.52	3.10	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.90	15.88	0.21	0.21	3.34	1.46	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.92	7.81	0.27	0.40	4.44	1.62	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	29.12	15.84	0.34	0.17	2.04	0.51	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.81	21.40	0.39	0.00	5.01	1.35	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	9.97	6.36	0.52	0.34	3.27	2.75	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	22.91	16.19	0.27	0.41	2.47	1.37	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.13	14.45	0.66	0.99	6.40	1.48	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.80	7.84	0.68	0.51	5.11	0.51	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	22.19	15.54	0.74	0.15	4.29	1.63	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	29.59	19.19	0.53	0.27	4.80	1.07	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	13.27	8.57	0.00	0.00	4.01	0.97	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.43	13.57	0.00	0.24	2.62	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	38.29	29.83	0.81	0.81	5.64	1.01	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	10.08	8.95	0.57	0.00	2.73	1.98	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.20	24.11	0.35	0.00	5.24	2.10	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	26.29	23.87	0.91	0.30	3.02	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.18	10.53	0.24	0.12	2.57	1.84	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	56.18	32.17	1.02	0.44	4.37	1.16	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.20	13.99	0.61	0.00	1.22	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	7.84	6.03	1.21	0.00	2.41	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.46	19.90	0.68	0.23	4.30	1.36	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	28.76	29.65	1.20	0.60	4.79	2.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.75	10.63	0.71	0.00	4.01	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.12	16.65	0.43	0.00	3.84	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	21.64	23.44	0.60	0.00	2.40	0.00	0.00
Schwann Cells, donor1	11498-119F4	12.04	12.98	1.50	0.19	4.89	1.69	1.13
Schwann Cells, donor2	11578-120F3	3.40	17.01	0.00	0.00	3.40	3.40	3.40
Schwann Cells, donor3	11659-122F3	8.98	7.89	0.44	0.44	2.19	0.88	1.10
Sebocyte, donor1	11220-116B5	40.53	40.53	6.57	0.55	2.74	0.55	0.00
Sebocyte, donor2	11301-117B5	19.30	19.76	1.38	0.46	0.92	0.92	2.76
Sebocyte, donor3	11378-118B1	16.70	16.90	3.50	0.41	2.27	2.27	0.41
Sertoli Cells, donor1	11255-116F4	11.60	9.94	0.00	0.00	4.97	0.00	1.66
Sertoli Cells, donor2	11333-117F1	5.65	14.12	0.00	0.00	2.82	2.82	5.65
Skeletal Muscle Cells, donor1	11281-116I3	24.72	19.00	1.06	0.44	4.84	2.29	1.41
Skeletal Muscle Cells, donor2	11358-117H8	5.78	10.12	0.72	0.00	3.61	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	12.54	11.70	3.34	0.00	1.67	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	6.13	6.91	0.63	0.00	1.26	1.26	0.79
Skeletal Muscle Cells, donor5	11455-119A6	5.65	5.95	0.74	0.45	1.04	1.04	0.15
Skeletal Muscle Cells, donor6	11459-119B1	6.16	10.62	0.92	0.46	2.62	1.69	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	8.69	13.86	3.40	0.13	3.40	2.14	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	9.70	11.42	1.85	0.00	3.00	2.28	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	13.79	14.98	1.49	0.50	2.28	1.39	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.87	15.33	1.77	0.25	5.90	1.94	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	24.61	23.16	5.07	0.00	0.72	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.60	9.08	2.06	0.28	1.24	0.41	0.41
Skin - palm, donor1	10286-104F7	102.07	24.17	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.48	3.75	0.43	0.14	1.30	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	7.36	2.45	0.00	3.27	3.27	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.49	5.19	0.39	0.13	1.43	0.91	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	10.29	9.45	0.70	0.14	4.31	2.09	1.81
Small Airway Epithelial Cells, donor2	11334-117F2	17.44	15.75	1.55	0.56	4.50	2.11	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	21.78	26.64	3.38	0.21	1.48	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	29.31	24.88	2.40	0.90	2.92	2.40	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.94	2.47	2.47	0.00	4.63	1.54	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3.33	3.11	0.44	0.22	1.78	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	6.47	11.76	2.35	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.90	15.25	0.88	0.22	2.21	1.10	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.60	9.06	0.79	0.00	1.18	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.18	6.18	0.77	0.00	1.55	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	4.00	11.01	1.00	0.00	4.00	2.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.92	8.78	0.40	0.13	0.53	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	6.43	6.43	1.33	0.00	2.66	0.89	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	2.82	1.79	0.38	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5.86	3.58	0.65	0.00	0.65	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	6.50	3.84	1.48	0.30	0.30	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6.98	5.98	0.85	0.00	1.57	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.32	10.74	1.46	0.00	3.25	1.30	2.93
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.61	14.00	1.83	0.00	2.13	2.74	2.44
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.62	12.38	2.78	0.51	2.27	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	18.36	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	5.72	0.00	0.48	1.43	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	4.57	7.08	0.88	0.15	1.33	0.15	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	5.17	5.38	0.86	0.00	1.72	1.29	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.14	10.60	1.47	0.00	2.31	0.73	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.17	12.22	0.62	0.00	0.62	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	6.47	3.23	0.00	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	3.29	8.37	0.60	0.00	0.90	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	20.83	14.00	2.05	0.34	4.10	2.05	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.68	9.03	2.12	0.39	4.95	2.12	1.57
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.96	8.15	0.70	0.20	2.01	0.40	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.74	12.97	1.37	0.46	4.10	1.14	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	1.81	0.00	0.00	0.60	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.16	15.10	1.85	1.06	1.32	0.26	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.39	8.39	0.67	0.13	1.46	1.46	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.15	12.02	1.63	0.50	2.63	2.25	1.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	6.09	0.76	0.25	0.51	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.24	8.74	1.06	0.00	1.81	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	8.25	1.50	0.00	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	54.27	47.81	7.75	1.29	9.05	6.46	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.44	11.16	1.86	0.47	0.93	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	10.60	1.51	1.01	2.02	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	6.27	1.25	0.00	0.63	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.96	6.49	0.88	0.29	1.47	2.36	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	16.24	9.16	1.42	0.17	0.83	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.34	6.54	0.93	0.47	2.80	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.69	9.64	1.01	0.14	0.86	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.24	11.73	2.80	0.00	1.02	1.02	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.26	9.03	0.94	0.19	1.50	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	10.48	5.31	1.12	0.84	2.10	1.40	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8.21	4.11	1.26	0.00	0.84	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	14.29	0.00	0.48	2.38	0.95	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.48	9.79	2.69	0.00	0.73	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.72	6.19	0.66	0.44	1.55	1.33	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	2.63	7.31	0.59	0.00	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.03	7.77	0.78	0.00	1.17	0.58	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.58	4.23	0.00	0.00	1.06	1.32	2.38
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.98	2.23	0.37	0.37	1.12	1.12	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.47	5.75	0.36	0.00	1.08	1.44	3.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.69	4.83	0.85	0.00	0.28	1.14	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.24	7.48	1.97	0.00	2.36	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	5.59	4.32	0.76	0.25	0.76	2.03	2.54
Smooth muscle cells - airway, control, donor2	11967-126D5	3.99	5.99	0.00	0.00	1.60	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	6.69	3.34	0.00	0.00	0.00	2.93	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	2.75	3.67	0.46	0.00	0.92	0.46	0.46
Synoviocyte, donor1	11291-117A4	22.39	10.27	0.50	0.34	3.20	0.84	1.01
Synoviocyte, donor2	11368-117I9	7.54	8.05	0.34	0.17	1.51	1.34	1.17
Synoviocyte, donor3	11440-118H9	6.93	8.27	0.22	0.00	0.89	1.34	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	23.23	4.29	0.71	3.93	4.29	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	25.77	1.98	1.98	9.91	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	26.40	21.07	3.70	0.00	5.79	2.55	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	12.04	15.48	1.94	0.22	0.65	0.36	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	5.80	7.73	0.77	0.00	1.16	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	6.30	0.57	0.00	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	21.90	25.71	2.71	0.49	6.77	1.60	0.74
Urethra, donor2	10319-105A4	25.18	61.15	0.00	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	8.77	8.77	1.06	0.00	1.86	1.86	1.06
Urothelial Cells, donor2	11600-120H7	2.40	9.21	0.40	0.40	3.20	1.20	0.80
Urothelial Cells, donor3	11681-122H7	7.79	12.15	0.46	0.23	2.29	0.69	1.60
Urothelial cells, donor0	11216-116B1	6.46	12.04	0.67	0.22	4.46	1.78	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.04	56.95	1.78	0.89	14.24	3.56	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	54.33	62.90	1.43	0.00	11.44	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	52.02	68.45	2.05	0.00	15.06	8.90	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	44.42	46.83	0.34	0.69	6.89	3.10	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	37.77	49.39	0.00	0.00	9.88	3.49	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	31.24	38.53	0.00	0.00	11.45	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.96	47.73	1.84	0.00	12.85	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	38.34	74.86	0.91	2.74	15.52	3.65	0.00
Wilms' tumor cell line:G-401	10809-111A8	18.87	19.49	2.10	0.74	4.81	2.96	2.59
Wilms' tumor cell line:HFWT	10597-108E3	66.88	68.64	4.40	0.00	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	17.04	17.04	1.40	0.84	4.19	2.23	1.96
achilles tendon, donor2	10292-104G4	20.67	12.40	0.00	2.07	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	36.71	22.44	0.76	0.51	2.80	3.57	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	33.90	23.91	1.86	0.23	4.88	2.55	3.71
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	77.40	34.19	1.19	0.47	5.34	4.87	3.44
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	31.57	20.68	1.63	0.54	4.35	3.54	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	20.24	15.46	2.25	0.28	8.43	7.31	3.94
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	13.75	12.05	0.63	0.21	0.42	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	19.87	19.87	1.09	0.82	2.99	1.63	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.78	14.54	1.76	0.00	1.76	2.64	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	18.38	15.11	1.63	0.41	2.04	3.27	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	31.45	22.52	2.72	0.00	3.11	1.55	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.40	15.09	1.66	0.37	6.26	3.50	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	15.60	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	19.98	16.50	1.39	0.70	6.97	4.88	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	42.98	38.58	1.29	1.55	16.83	12.43	5.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	18.41	20.75	1.17	0.00	7.31	6.14	3.21
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.98	25.10	1.86	0.00	5.11	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	19.74	17.68	1.23	0.00	3.29	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	14.73	15.04	1.23	0.00	0.61	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	10.67	15.36	2.13	0.43	5.55	2.56	3.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	11.53	15.77	2.12	0.61	2.43	0.91	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	17.09	18.29	2.17	0.00	2.41	2.65	2.65
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.49	8.02	0.67	0.45	2.23	2.67	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	30.35	12.67	2.00	0.00	5.67	1.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	42.74	5.57	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.16	8.66	0.38	0.38	0.75	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.09	28.35	1.74	0.87	4.36	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	74.98	50.61	0.00	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	18.13	14.60	1.88	0.24	1.18	0.94	1.18
adipose tissue, adult, pool1	10010-101C1	19.70	33.20	0.93	1.09	6.67	1.24	0.78
adipose, donor1	10184-103D4	24.04	35.18	1.76	1.76	11.73	5.86	0.00
adipose, donor2	10185-103D5	23.52	17.84	0.81	0.00	1.22	0.81	0.81
adipose, donor3	10186-103D6	24.51	18.52	0.82	0.00	2.72	1.36	0.27
adipose, donor4	10187-103D7	39.87	23.40	3.47	0.00	7.80	4.33	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	19.41	33.46	2.68	0.32	2.37	1.58	0.32
adrenal gland, adult, pool1	10081-102A9	18.19	10.91	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.47	16.68	1.07	0.40	3.74	0.80	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	6.79	6.07	0.71	0.00	2.14	1.43	0.36
amniotic membrane cells, donor1	12235-129G3	6.03	13.91	1.62	0.00	0.93	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	9.47	12.51	1.35	0.00	0.00	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	8.84	12.96	0.59	0.00	1.18	1.77	0.59
amygdala - adult, donor10196	10167-103B5	27.27	32.02	1.19	3.56	3.56	8.30	2.37
amygdala, adult, donor10252	10151-102I7	45.01	54.34	2.84	2.23	6.29	2.43	1.42
amygdala, newborn, donor10223	10360-105E9	29.05	20.01	1.61	0.00	3.23	1.29	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	16.17	12.73	2.29	0.38	2.55	2.55	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.80	19.41	1.76	0.22	3.75	2.21	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.45	49.10	2.34	2.00	4.34	2.00	0.67
aorta, adult, pool1	10052-101G7	24.71	34.52	1.96	0.78	7.85	2.16	0.39
appendix, adult	10189-103D9	29.50	27.94	0.78	1.16	4.27	1.94	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.10	10.66	0.00	0.34	2.06	2.06	0.69
artery, adult	10190-103E1	21.74	20.38	0.00	0.00	2.72	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	9.56	14.92	0.58	0.58	1.45	0.87	0.87
b cell line:RPMI1788	10427-106D4	13.23	17.84	1.93	0.15	3.72	3.57	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.16	9.43	0.83	0.00	0.83	1.39	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	13.20	11.41	0.99	0.30	3.18	1.19	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	12.39	8.87	0.84	0.00	2.68	1.00	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	25.17	17.34	0.56	0.00	0.56	1.68	1.12
bladder, adult, pool1	10011-101C2	17.38	36.61	1.41	0.33	7.39	2.50	1.20
blood, adult, pool1	10053-101G8	37.65	17.72	2.21	2.21	6.64	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	28.26	23.98	5.14	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	16.20	17.55	0.00	0.00	6.75	2.70	0.67
brain, adult, donor1	10084-102B3	23.58	16.40	1.03	1.03	5.13	3.08	0.00
brain, adult, pool1	10012-101C3	32.85	25.28	1.11	0.78	8.02	2.34	2.56
brain, fetal, pool1	10085-102B4	21.37	26.71	5.34	0.00	8.01	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	28.41	20.15	1.32	1.32	4.29	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	26.84	24.59	1.00	0.87	5.87	1.75	2.12
breast, adult, donor1	10080-102A8	11.36	23.99	1.89	0.00	1.26	1.89	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.04	14.10	1.14	0.51	3.56	3.05	1.52
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.06	11.13	0.31	0.31	1.55	1.86	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2.07	8.75	0.69	0.46	2.76	2.07	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	20.34	10.65	3.15	0.24	1.94	1.69	0.73
carcinoid cell line:NCI-H1770	10703-109H1	9.87	18.81	0.47	0.47	2.35	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	134.98	56.88	3.83	0.98	5.14	3.50	2.95
carcinoid cell line:SK-PN-DW	10719-109I8	12.99	10.14	0.00	0.32	2.22	1.58	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	23.69	29.81	3.99	1.33	11.98	5.86	2.66
caudate nucleus - adult, donor10196	10177-103C6	20.72	25.33	0.00	1.15	4.61	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	43.34	47.69	2.01	1.34	7.70	2.18	1.67
caudate nucleus, adult, donor10258	10379-105H1	12.99	17.58	0.00	0.00	4.58	1.53	3.06
caudate nucleus, newborn, donor10223	10354-105E3	33.69	14.65	0.73	0.37	5.49	2.20	1.46
cerebellum - adult, donor10196	10173-103C2	23.31	46.61	2.91	0.00	2.91	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	64.48	95.01	1.28	0.85	12.38	7.05	1.28
cerebellum, adult, pool1	10083-102B2	17.59	13.45	0.69	0.00	3.79	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	37.36	32.38	3.32	0.00	9.13	0.83	0.00
cerebral meninges, adult	10188-103D8	16.64	16.89	0.76	0.25	1.26	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	19.73	9.50	0.73	0.00	0.00	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	9.20	12.94	2.59	0.86	5.03	3.74	1.29
cervical cancer cell line:ME-180	10553-107I4	37.45	20.38	2.98	0.50	4.14	2.82	2.32
cervix, adult, pool1	10013-101C4	30.45	41.05	1.05	0.63	8.40	1.68	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	19.37	10.03	1.67	0.28	1.53	0.70	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	32.66	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	25.23	16.16	2.24	0.62	6.71	2.49	4.72
choriocarcinoma cell line:SCH	10785-110H2	29.57	24.40	3.94	0.86	4.19	3.08	3.08
choriocarcinoma cell line:T3M-3	10618-108G6	22.77	23.01	4.03	0.95	1.90	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	6.27	11.11	2.28	0.00	0.85	0.57	1.14
chorionic membrane cells, donor2	12239-129G7	14.52	16.31	1.89	0.10	1.69	0.70	0.30
chorionic membrane cells, donor3	12240-129G8	6.59	18.13	2.75	1.10	4.40	2.20	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	13.13	6.06	0.00	0.00	4.04	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	11.91	16.14	0.58	0.77	1.73	1.73	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	28.09	30.41	3.17	0.42	2.96	1.27	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	14.38	22.86	2.57	1.54	4.37	2.82	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	21.77	29.03	1.45	1.45	10.16	3.39	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.84	25.45	2.85	0.41	9.77	2.65	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	22.38	25.62	1.77	0.29	2.65	1.47	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	48.22	39.62	4.43	1.30	12.25	7.82	3.39
clear cell carcinoma cell line:JHOC-5	10638-108I8	4.11	12.57	0.69	0.46	3.66	2.29	1.14
clear cell carcinoma cell line:TEN	10636-108I6	15.10	13.36	1.56	1.04	1.56	0.87	0.35
colon carcinoma cell line:CACO-2	10513-107D9	21.60	15.38	1.28	0.18	2.38	1.46	0.92
colon carcinoma cell line:COLO-320	10420-106C6	26.61	23.95	0.00	0.00	4.94	4.56	3.80
colon, adult, donor1	10082-102B1	11.90	22.61	0.00	0.00	3.57	1.19	0.00
colon, adult, pool1	10014-101C5	21.03	23.50	1.18	0.35	4.11	0.82	0.35
colon, fetal, donor1	10070-101I7	18.54	19.16	1.24	0.00	1.85	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	178.76	174.17	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	48.02	28.05	1.27	0.00	2.97	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	22.34	16.90	1.06	0.15	1.81	0.45	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	20.02	17.91	1.41	0.28	2.40	0.99	0.56
corpus callosum, adult, pool1	10042-101F6	28.41	39.03	1.55	0.77	7.63	1.77	1.77
cruciate ligament, donor2	10295-104G7	31.61	14.59	1.62	0.00	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	8.83	21.67	1.61	1.61	4.01	3.21	1.61
diencephalon, adult	10193-103E4	11.04	11.52	0.24	0.00	1.68	1.44	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	22.04	19.98	0.00	0.69	9.41	8.27	2.98
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.05	14.87	0.51	0.00	2.56	0.77	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	17.09	15.41	1.69	0.96	2.65	3.13	2.17
ductus deferens, adult	10196-103E7	28.90	27.91	0.00	1.00	9.47	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	27.36	0.00	0.00	4.32	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	28.69	16.18	0.74	0.74	5.15	2.94	2.21
dura mater, adult, donor1	10041-101F5	66.73	36.83	2.31	0.91	11.07	2.64	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	47.08	11.33	0.67	0.22	1.55	1.11	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	22.50	15.48	0.86	0.14	1.58	1.15	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	30.83	41.93	4.93	1.23	0.62	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	6.05	17.25	2.12	0.00	2.72	2.12	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.76	36.43	5.87	0.31	2.47	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	23.64	56.48	7.88	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	37.21	28.16	1.34	0.34	1.68	2.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	11.78	30.09	2.90	0.91	5.26	3.81	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	8.20	7.08	0.48	0.16	2.73	2.09	0.64
epidermoid carcinoma cell line:A431	10426-106D3	27.12	21.45	1.22	0.33	2.89	1.00	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.40	14.74	2.09	0.00	4.62	3.08	1.65
epididymis, adult	10197-103E8	18.21	19.05	0.84	0.42	2.93	1.47	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	12.60	17.56	0.53	0.35	2.13	1.77	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.16	12.98	0.79	0.00	0.79	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	9.96	23.33	4.98	0.39	10.09	2.62	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	14.27	25.20	5.22	0.89	9.94	2.95	2.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	9.19	20.28	6.72	0.78	6.83	3.47	1.34
esophagus, adult, pool1	10015-101C6	16.99	20.49	1.17	0.74	5.84	1.27	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	90.67	59.86	6.76	0.75	14.78	7.01	4.63
eye - muscle inferior rectus, donor1	10272-104E2	38.63	21.73	2.41	0.00	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	14.73	0.00	0.00	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	22.32	1.49	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	18.34	27.52	0.00	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	37.89	20.40	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	18.30	28.47	1.27	1.02	4.07	3.81	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	11.54	13.98	1.03	0.00	1.92	2.18	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	15.91	22.08	0.71	1.19	4.99	3.09	0.71
frontal lobe, adult, pool1	10040-101F4	41.75	31.99	1.31	1.41	7.04	2.53	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	40.23	39.03	1.20	0.60	8.11	5.10	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.83	18.38	2.29	0.73	4.75	1.74	1.01
gall bladder, adult	10198-103E9	19.07	16.42	2.41	1.21	3.62	2.66	0.24
gamma delta positive T cells, donor1	11937-126A2	17.72	20.94	0.54	0.00	2.15	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	19.80	11.95	2.24	0.00	2.24	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.91	15.84	1.27	1.06	5.70	2.96	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	37.72	34.81	4.64	1.16	7.74	8.12	5.42
gastric cancer cell line:AZ521	10549-107H9	38.04	27.54	1.48	0.82	5.25	2.13	1.97
gastric cancer cell line:GSS	10560-108A2	30.20	21.05	1.83	0.00	9.15	3.66	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	64.65	34.95	1.60	0.91	13.02	5.03	1.14
giant cell carcinoma cell line:LU65	10487-107B1	8.95	9.64	0.11	0.23	3.10	1.84	1.49
giant cell carcinoma cell line:Lu99B	10433-106E1	9.38	17.77	1.82	0.42	4.90	2.38	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.71	11.72	2.74	0.00	2.00	1.00	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.78	12.67	1.06	0.21	2.43	0.74	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.15	15.73	0.70	0.14	1.69	1.12	0.70
glioblastoma cell line:T98G	10485-107A8	12.03	13.69	1.88	0.22	1.99	2.54	0.99
glioma cell line:GI-1	10413-106B8	12.01	17.57	2.05	0.00	4.39	2.64	1.17
globus pallidus - adult, donor10196	10175-103C4	12.39	13.12	2.92	0.00	1.46	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	29.29	55.65	2.20	0.98	7.57	2.93	0.98
globus pallidus, adult, donor10258	10367-105F7	6.85	19.17	0.00	0.00	5.48	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	20.25	11.19	0.00	0.53	2.13	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	107.67	144.38	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.44	19.52	2.24	0.64	1.60	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	6.89	9.18	0.46	0.00	3.67	3.67	4.13
hIPS +CCl2, biol_rep2	14384-156C1	9.60	6.86	0.91	0.00	5.03	4.12	4.57
hIPS +CCl2, biol_rep3	14385-156C2	8.37	5.15	0.64	0.00	1.93	1.29	1.93
hIPS, biol_rep1	14380-156B6	12.94	2.87	0.00	0.00	1.44	4.31	2.87
hIPS, biol_rep2	14381-156B7	2.74	4.12	1.37	0.00	0.00	1.37	0.69
hIPS, biol_rep3	14382-156B8	15.45	5.52	2.21	0.00	2.21	2.21	3.31
hairy cell leukemia cell line:Mo	10712-109I1	15.80	15.23	1.15	0.00	3.45	2.01	2.01
heart - mitral valve, adult	10205-103F7	16.44	31.99	2.09	0.00	4.19	2.69	0.30
heart - pulmonic valve, adult	10206-103F8	28.76	46.54	1.57	0.52	9.15	2.61	1.05
heart - tricuspid valve, adult	10207-103F9	24.15	32.47	0.83	0.00	7.49	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	16.32	26.32	1.63	0.20	4.90	3.47	1.84
heart, adult, diseased, donor1	10051-101G6	23.85	28.53	0.85	1.28	11.07	5.11	0.85
heart, adult, pool1	10016-101C7	14.26	26.91	2.30	0.23	0.46	0.46	0.00
heart, fetal, pool1	10046-101G1	40.87	47.44	2.05	0.92	11.19	2.46	1.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	13.88	15.43	0.62	1.54	0.62	3.09	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	156.97	80.86	8.32	1.19	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	52.26	28.51	3.87	0.99	11.05	3.54	2.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	53.40	32.53	4.73	0.97	12.26	4.13	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	59.12	37.89	5.56	1.41	12.63	4.45	2.83
hepatoma cell line:Li-7	10484-107A7	22.47	14.79	0.67	0.22	2.67	1.78	1.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.59	14.17	0.70	0.30	3.02	2.21	1.21
hippocampus - adult, donor10196	10169-103B7	21.77	13.25	1.89	0.95	6.62	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	33.47	49.19	4.08	1.43	9.18	3.27	1.02
hippocampus, adult, donor10258	10374-105G5	10.95	5.48	0.50	0.00	3.49	4.98	1.99
hippocampus, newborn, donor10223	10363-105F3	19.39	9.16	0.00	0.35	3.17	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	20.75	12.21	1.22	0.61	7.32	5.49	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	15.51	15.12	0.98	0.00	2.75	1.77	2.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	21.33	12.44	1.27	0.00	4.06	3.55	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	16.92	11.28	0.56	0.00	4.51	2.26	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	16.78	20.66	1.03	1.03	8.52	6.20	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.60	17.08	1.52	0.00	4.18	1.90	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	33.57	18.69	0.58	0.00	5.26	2.04	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.22	28.44	1.29	0.22	4.52	2.37	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.69	12.51	1.25	0.00	3.75	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.89	10.18	0.47	0.00	1.89	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.55	15.75	0.64	0.32	5.30	1.45	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	17.51	0.67	0.00	0.67	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.00	16.90	0.47	0.47	4.38	1.25	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	18.18	16.70	1.97	0.00	4.91	5.40	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	10.47	5.24	0.00	0.00	6.11	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	25.96	27.87	0.95	0.57	5.92	3.25	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	15.70	24.42	0.44	0.87	2.62	3.05	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	15.99	22.49	0.00	0.00	5.50	2.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	30.90	26.19	1.13	0.38	7.16	3.39	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	24.55	25.46	0.45	0.91	4.09	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	24.75	20.05	1.25	0.63	5.01	1.88	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.96	15.02	0.65	0.16	3.76	2.12	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.00	12.77	0.29	0.00	4.06	1.16	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.82	11.66	0.90	0.30	2.39	0.90	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.18	13.49	1.48	0.37	4.06	2.03	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.55	17.12	0.86	0.00	3.99	2.85	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	23.27	14.70	2.45	0.00	3.67	1.63	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	18.66	19.01	1.41	0.35	6.69	6.69	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.79	22.17	1.27	0.00	2.53	1.58	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.64	18.46	0.61	0.30	5.14	2.42	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.41	22.75	1.03	0.00	3.62	0.52	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.27	11.95	1.33	0.00	2.66	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	24.88	12.57	0.77	0.00	1.80	1.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.43	10.74	0.26	0.00	3.58	0.51	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	23.47	12.87	0.00	0.00	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	17.14	8.40	0.00	0.00	2.02	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	17.15	14.97	1.45	0.00	3.14	2.90	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.05	6.24	0.45	0.00	3.12	2.23	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.56	12.68	0.49	0.00	2.93	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	23.53	26.89	1.22	0.00	6.11	3.67	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	26.03	26.03	6.51	0.00	48.80	39.04	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.15	12.91	2.32	0.00	7.94	2.32	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.82	29.55	0.55	0.55	2.74	1.64	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	29.31	13.03	0.36	0.00	4.70	2.53	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.91	13.88	0.71	0.00	3.56	1.78	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	10.74	0.00	0.00	2.39	2.39	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	30.34	15.17	1.08	0.00	4.20	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.97	6.73	0.00	0.00	1.89	1.35	0.27
immature langerhans cells, donor1	11904-125F5	47.46	17.92	0.73	0.48	1.21	1.70	0.00
immature langerhans cells, donor2	11905-125F6	23.76	19.80	0.00	0.00	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	56.87	41.07	1.89	0.66	10.13	2.74	1.70
keratoacanthoma cell line:HKA-1	10791-110H8	11.71	8.78	0.00	0.00	0.33	0.65	0.65
kidney, adult, pool1	10017-101C8	23.33	22.43	1.80	0.40	4.31	1.60	0.90
kidney, fetal, pool1	10045-101F9	44.99	43.64	2.41	1.06	11.03	2.19	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.00	24.29	1.56	0.28	1.85	0.57	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.22	4.98	0.83	0.00	1.38	0.97	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	37.98	30.83	1.65	0.55	2.94	1.65	1.10
left atrium, adult, donor1	10079-102A7	9.26	10.35	0.54	0.00	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	9.10	14.16	0.51	1.01	3.54	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	32.29	23.80	0.55	0.27	2.46	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	3.59	3.59	0.72	0.00	2.87	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	3.26	4.89	0.54	0.00	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	3.89	5.10	0.73	0.24	3.16	1.46	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	26.14	3.14	0.00	4.18	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	55.49	34.71	2.60	1.42	7.08	4.13	3.07
liposarcoma cell line:KMLS-1	10782-110G8	6.56	7.34	0.47	0.00	1.25	0.94	0.78
liposarcoma cell line:SW 872	10726-110A6	12.91	14.01	2.07	0.12	1.95	1.22	0.73
liver, adult, pool1	10018-101C9	15.40	11.67	1.78	0.32	5.35	1.13	1.46
liver, fetal, pool1	10086-102B5	8.47	9.41	0.00	0.00	0.94	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.96	24.21	1.02	0.87	3.21	0.87	1.02
locus coeruleus, adult, donor10252	10165-103B3	26.02	35.43	3.32	0.92	6.27	2.21	1.29
locus coeruleus, adult, donor10258	10375-105G6	10.44	7.05	0.28	0.28	1.69	1.41	0.85
locus coeruleus, newborn, donor10223	10362-105F2	22.71	21.87	3.36	0.42	5.05	1.68	1.26
lung adenocarcinoma cell line:A549	10499-107C4	13.01	10.24	0.55	0.42	1.38	1.25	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	39.30	46.88	5.52	0.00	2.07	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	18.32	18.06	1.19	0.13	2.37	1.58	0.40
lung, adult, pool1	10019-101D1	16.18	30.36	1.42	0.59	4.61	2.01	1.18
lung, fetal, donor1	10068-101I5	31.11	47.09	2.57	0.86	3.71	2.00	1.14
lung, right lower lobe, adult, donor1	10075-102A3	10.54	21.08	1.37	0.46	7.33	4.12	0.00
lymph node, adult, donor1	10077-102A5	17.99	14.67	1.42	0.95	5.68	2.84	0.47
lymphangiectasia cell line:DS-1	10727-110A7	11.84	12.27	1.53	0.22	2.41	1.32	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	21.73	17.21	1.66	0.30	0.91	1.21	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	113.83	56.07	7.65	0.85	27.18	5.10	4.25
mature adipocyte, donor1	12231-129F8	26.20	29.30	2.22	0.00	1.78	0.00	0.00
mature adipocyte, donor2	12232-129F9	12.04	13.49	0.42	0.42	1.04	0.42	0.00
mature adipocyte, donor3	12233-129G1	9.72	23.00	2.13	0.24	0.95	0.24	0.00
mature adipocyte, donor4	12234-129G2	12.37	18.95	1.32	0.00	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	68.86	32.64	4.05	1.19	10.96	4.05	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	13.54	1.13	1.13	7.90	4.51	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	47.08	56.09	3.86	1.66	9.20	4.60	2.39
medial frontal gyrus, adult, donor10258	10368-105F8	11.75	4.77	0.95	0.00	5.40	3.49	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	34.55	15.35	3.41	0.85	10.24	6.40	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	36.96	39.49	2.19	1.35	17.04	16.88	3.88
medial temporal gyrus, adult, donor10252	10156-103A3	57.94	62.39	2.55	1.49	8.70	4.24	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	7.71	0.00	0.00	0.00	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	14.35	14.35	272.72	71.77	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	30.51	20.10	1.08	0.00	2.87	2.15	0.72
medulla oblongata - adult, donor10196	10174-103C3	7.79	12.33	0.65	0.65	1.30	3.24	0.65
medulla oblongata, adult, donor10252	10155-103A2	25.39	45.20	2.79	0.93	8.20	2.01	1.24
medulla oblongata, adult, pool1	10038-101F2	39.34	32.32	1.39	0.33	6.20	1.39	0.82
medulla oblongata, newborn, donor10223	10361-105F1	20.48	21.87	1.74	0.00	2.43	0.35	1.39
medulloblastoma cell line:D283 Med	10838-111E1	36.98	31.22	0.89	0.44	12.18	8.19	4.65
medulloblastoma cell line:ONS-76	10759-110E3	33.50	21.76	1.71	0.37	1.83	1.47	0.61
melanoma cell line:COLO 679	10514-107E1	22.86	11.64	0.86	0.00	2.73	0.86	0.43
melanoma cell line:G-361	10465-106H6	13.30	11.94	0.81	0.27	2.44	2.71	1.90
meningioma cell line:HKBMM	10691-109F7	5.43	8.86	0.90	0.36	1.99	2.17	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.01	30.84	0.00	0.00	12.34	5.29	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	38.88	33.96	0.26	0.78	3.11	2.07	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	5.68	6.90	1.23	0.15	1.38	1.23	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.91	10.91	1.82	0.36	3.09	2.54	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	1.24	2.07	1.24	0.00	2.07	0.83	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	3.65	6.46	1.26	0.14	0.70	0.98	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.78	7.13	1.35	0.58	1.35	0.77	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.11	5.55	0.69	0.00	2.78	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.66	7.21	2.23	0.17	0.34	1.20	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	6.79	8.51	1.38	0.23	2.19	0.92	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	3.85	8.09	0.27	0.00	1.59	0.66	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.59	4.59	1.22	0.00	2.16	0.95	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.83	7.68	1.85	0.00	2.85	1.42	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.19	7.90	1.65	0.00	3.29	1.65	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	5.95	7.47	3.04	0.55	1.11	0.42	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5.93	7.68	0.35	0.00	1.40	1.75	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.45	5.72	0.82	0.20	1.02	0.82	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.94	6.83	0.36	0.36	1.44	1.08	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	1.66	5.07	1.03	0.41	1.14	0.62	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.38	2.96	0.68	0.00	0.68	1.14	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.03	5.03	0.42	0.00	2.10	0.84	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	3.29	5.23	1.34	0.00	1.49	0.90	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	4.38	6.21	1.31	0.35	2.01	1.49	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.89	5.52	0.37	0.00	0.74	0.37	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	7.44	8.01	1.14	0.29	0.86	1.14	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.53	11.37	1.68	0.00	1.68	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.68	5.02	0.00	0.00	1.37	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.09	4.86	1.28	0.00	1.28	2.05	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	4.97	3.14	1.57	0.00	1.05	0.52	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	5.55	6.16	0.92	0.31	1.23	2.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.94	4.00	2.35	0.00	2.82	1.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.75	5.08	1.35	0.00	2.37	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	3.93	5.11	1.57	0.00	2.36	1.57	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.02	5.10	0.93	0.00	0.93	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7.79	7.21	1.44	0.00	2.88	1.73	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.25	6.02	0.22	0.00	1.56	0.45	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.09	6.01	0.48	0.00	1.44	0.96	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	14.67	8.80	1.47	0.73	3.67	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.03	5.71	0.00	0.00	1.68	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.50	3.68	0.41	0.00	1.23	2.87	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.15	2.58	0.00	0.00	2.15	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	5.47	2.73	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.82	5.52	0.97	0.00	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	4.36	1.45	0.00	1.45	1.45	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	5.86	0.53	0.00	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	2.45	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.44	7.39	0.78	0.39	0.39	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	4.20	0.00	0.00	6.30	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	7.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.34	5.34	0.00	0.00	1.78	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	9.75	1.22	0.00	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.17	2.53	0.00	0.00	1.90	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.79	2.76	1.38	0.00	0.34	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	10.75	4.30	0.00	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	3.99	7.98	0.00	3.99	11.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	0.00	0.00	10.33	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.07	1.22	1.22	0.41	2.85	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	2.38	0.00	0.00	0.00	2.38	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.72	2.95	1.18	0.00	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.36	2.49	1.56	0.00	0.62	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	5.35	0.00	0.00	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	3.55	2.37	0.00	2.37	3.55	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	0.00	0.00	5.14	5.14	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	3.44	5.51	0.00	0.00	1.38	2.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	2.97	1.48	0.00	0.99	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	1.12	3.36	0.00	0.00	1.12	2.24	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.27	3.82	0.64	0.64	1.91	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1.61	2.01	0.40	0.00	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	2.53	1.27	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.86	7.28	0.61	0.00	1.82	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	9.04	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.82	2.47	0.00	0.00	4.94	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.97	2.58	0.00	0.20	0.60	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1.95	2.60	0.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	0.00	3.06	0.00	0.00	1.02	2.04	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.07	41.01	3.09	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	14.88	29.53	1.42	0.94	3.07	0.47	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	18.77	12.28	2.78	0.70	3.48	1.16	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	4.27	0.00	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	16.34	9.25	1.23	0.10	3.19	4.32	0.82
mesothelioma cell line:Mero-25	10850-111F4	55.15	21.79	1.59	0.45	9.53	11.35	6.58
mesothelioma cell line:Mero-41	10851-111F5	14.18	13.45	1.22	0.73	3.42	4.40	3.42
mesothelioma cell line:Mero-48a	10852-111F6	8.86	7.53	0.44	0.00	2.44	2.21	0.89
mesothelioma cell line:Mero-82	10853-111F7	34.16	17.35	2.10	1.31	6.57	7.88	3.42
mesothelioma cell line:Mero-83	10854-111F8	19.75	11.40	0.51	0.17	3.74	3.57	1.70
mesothelioma cell line:Mero-84	10855-111F9	12.89	9.61	1.77	0.25	3.03	2.02	2.27
mesothelioma cell line:Mero-95	10856-111G1	11.18	11.39	1.04	0.21	3.11	2.90	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	10.77	5.63	0.83	0.17	1.82	2.15	1.99
mesothelioma cell line:NCI-H226	10846-111E9	17.01	6.88	1.09	0.54	4.52	1.99	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	14.69	11.96	1.20	0.17	3.42	4.61	2.22
mesothelioma cell line:NCI-H28	10845-111E8	9.16	7.13	0.51	0.00	5.09	1.78	1.78
mesothelioma cell line:No36	10857-111G2	11.09	10.44	1.96	0.00	4.24	2.28	1.96
mesothelioma cell line:ONE58	10858-111G3	17.34	8.40	0.54	0.27	2.17	2.98	0.81
migratory langerhans cells, donor1	11901-125F2	34.35	17.85	1.34	0.77	2.11	1.92	0.77
migratory langerhans cells, donor2	11902-125F3	18.93	20.52	0.49	0.12	1.47	0.98	0.37
migratory langerhans cells, donor3	11903-125F4	15.08	13.46	0.36	0.18	0.90	1.97	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	24.81	18.94	1.96	0.33	4.57	5.22	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.30	6.78	0.64	0.00	0.85	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	65.42	36.17	2.76	0.00	0.92	0.69	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.56	7.80	0.76	0.57	0.38	1.52	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	29.94	24.21	1.48	0.55	1.85	3.14	0.74
myeloma cell line:PCM6	10474-106I6	15.62	20.95	0.40	0.00	2.97	1.19	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	19.28	27.39	2.03	1.01	3.04	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.44	17.06	1.57	0.78	3.14	1.57	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.92	8.91	0.22	0.22	0.45	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.99	6.55	0.37	0.15	0.44	0.29	0.07
nasal epithelial cells, donor2	12227-129F4	29.81	14.35	1.10	0.00	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	80.06	61.20	3.68	0.23	5.06	2.99	0.92
neuroblastoma cell line:NB-1	10539-107G8	23.57	22.64	0.75	1.12	3.18	2.06	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	60.74	27.63	4.01	1.27	6.33	4.43	3.37
neuroblastoma cell line:NH-12	10555-107I6	46.77	38.95	2.42	1.68	4.47	5.59	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	22.30	25.86	1.66	0.95	6.41	4.51	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	25.50	22.97	0.48	0.48	4.91	3.33	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	20.73	17.51	0.60	0.81	1.61	2.42	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	84.56	55.95	2.54	0.64	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	22.36	7.72	0.27	0.00	1.60	1.86	0.27
neutrophil PMN, donor1	12133-128D9	252.87	297.50	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	39.84	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	27.74	36.19	1.01	1.35	9.64	6.93	2.88
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	9.61	0.00	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.73	10.90	0.64	0.32	1.28	1.92	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.15	9.72	0.00	0.26	1.84	1.05	1.05
nucleus accumbens, adult, pool1	10037-101F1	47.24	37.50	2.06	0.75	10.22	2.25	1.31
occipital cortex - adult, donor10196	10172-103C1	26.78	26.78	4.12	0.00	12.36	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	60.65	66.02	4.29	1.88	6.71	4.29	1.34
occipital cortex, newborn, donor10223	10355-105E4	34.94	18.20	1.09	0.00	8.37	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	19.94	19.94	0.52	0.00	2.89	0.26	0.79
occipital lobe, fetal, donor1	10073-102A1	20.60	20.60	2.15	0.43	3.43	2.57	0.86
occipital pole, adult, pool1	10036-101E9	41.94	27.83	1.42	0.63	7.02	2.37	1.58
olfactory region, adult	10195-103E6	26.56	23.88	1.15	0.76	5.54	2.48	0.38
optic nerve, donor1	10277-104E7	24.01	28.01	0.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	29.96	30.98	2.96	1.48	7.06	5.35	2.96
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.05	10.85	0.55	0.14	2.89	1.10	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.77	11.85	0.51	0.34	4.23	2.20	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	20.91	13.63	2.43	0.81	4.27	4.04	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	27.34	13.23	1.18	0.29	2.35	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	111.19	135.48	9.34	0.93	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	21.84	20.99	1.06	0.64	2.76	1.91	1.27
ovary, adult, pool1	10020-101D2	17.21	32.93	0.87	0.52	8.12	1.92	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.93	14.67	0.55	0.18	2.02	0.92	1.47
pancreas, adult, donor1	10049-101G4	28.22	23.52	0.94	0.94	4.70	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	18.73	14.82	2.24	0.56	1.40	0.84	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	25.72	12.44	1.36	0.34	4.94	5.11	2.56
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	17.88	16.89	1.82	0.50	6.62	2.32	2.15
paracentral gyrus, adult, pool1	10035-101E8	41.09	30.02	1.10	1.19	7.69	2.11	1.56
parietal cortex, adult, donor10258	10373-105G4	17.62	9.54	1.47	0.00	1.47	5.14	1.47
parietal lobe - adult, donor10196	10171-103B9	21.63	23.51	0.94	0.00	7.52	3.76	0.94
parietal lobe, adult, donor10252	10157-103A4	46.75	52.45	2.85	1.14	12.54	5.13	2.57
parietal lobe, adult, pool1	10034-101E7	44.24	34.81	1.67	0.88	6.26	1.67	1.67
parietal lobe, fetal, donor1	10072-101I9	30.06	29.10	1.94	0.97	6.79	4.85	0.00
parietal lobe, newborn, donor10223	10356-105E5	48.60	26.17	0.75	0.00	11.22	2.99	1.87
parotid gland, adult	10199-103F1	27.75	19.73	0.00	0.00	1.23	0.62	1.85
penis, adult	10200-103F2	22.02	27.39	0.00	0.54	8.59	2.69	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	17.48	30.31	1.30	1.67	15.80	5.76	2.05
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	13.55	14.13	0.87	0.58	2.91	3.50	1.46
pineal gland - adult, donor10196	10179-103C8	16.13	32.25	1.29	0.00	1.94	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	37.90	45.01	3.55	0.59	18.95	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	10.03	9.41	1.25	0.00	4.39	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	10.12	35.41	2.02	1.01	7.08	2.02	6.07
pituitary gland, adult, donor10252	10162-103A9	43.78	61.50	2.61	1.04	11.47	4.69	1.56
pituitary gland, adult, donor10258	10378-105G9	2.55	11.07	0.00	0.00	4.26	2.55	0.85
placenta, adult, pool1	10021-101D3	26.45	29.78	2.47	0.65	6.99	2.47	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	28.07	14.17	2.12	0.53	2.65	2.12	1.32
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	9.34	13.38	2.02	0.47	0.78	0.00	0.31
pons, adult, pool1	10033-101E6	29.09	23.67	1.20	0.34	5.42	1.55	0.77
postcentral gyrus, adult, pool1	10032-101E5	42.02	30.86	1.31	1.13	9.15	2.44	2.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	66.92	92.02	4.18	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	5.54	12.09	1.46	0.15	2.33	2.77	1.46
prostate cancer cell line:PC-3	10439-106E7	28.13	24.87	1.63	0.73	6.35	2.00	2.72
prostate, adult, pool1	10022-101D4	15.15	27.48	1.00	0.36	4.26	1.00	0.91
putamen, adult, donor10196	10176-103C5	41.31	63.50	4.49	2.12	11.57	2.60	2.12
putamen, adult, donor10252	10152-102I8	35.29	17.65	0.00	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	1.09	1.09	0.00	3.28	2.19	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	14.50	15.95	0.48	0.24	4.11	4.11	2.17
putamen, newborn, donor10223	10365-105F5	14.24	11.24	0.00	0.75	11.24	5.25	1.50
rectal cancer cell line:TT1TKB	10469-106I1	50.91	52.37	2.04	0.87	5.53	2.91	0.29
rectum, fetal, donor1	10067-101I4	19.47	19.47	0.00	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	11.24	9.75	0.64	0.21	3.18	2.97	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.49	10.36	1.66	0.00	1.24	1.66	1.66
retina, adult, pool1	10030-101E3	28.83	38.57	1.19	1.19	9.64	2.78	1.69
retinoblastoma cell line:Y79	10475-106I7	31.96	23.90	1.56	0.26	4.16	2.86	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.67	25.08	4.30	0.61	4.43	2.70	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	186.15	157.47	3.66	2.25	20.53	9.84	4.78
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.83	39.41	3.03	0.00	2.27	0.76	0.00
salivary acinar cells, donor1	11771-123I7	9.39	10.68	1.29	0.65	3.40	3.40	1.29
salivary acinar cells, donor2	11772-123I8	11.43	10.19	1.24	0.55	2.48	2.20	1.10
salivary acinar cells, donor3	11773-123I9	37.07	37.07	2.65	0.66	3.31	0.66	0.66
salivary gland, adult, pool1	10093-102C3	14.87	19.45	0.57	0.57	2.29	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.20	14.33	1.85	0.25	2.87	2.53	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.93	17.05	1.41	0.47	2.59	1.65	1.29
seminal vesicle, adult	10201-103F3	28.04	29.63	0.53	1.06	5.82	1.06	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.41	8.50	1.94	0.49	3.64	1.94	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.82	9.06	0.50	0.25	0.25	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	10.04	21.07	0.00	0.00	5.02	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	9.81	11.01	0.40	0.40	3.49	2.42	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	29.18	9.51	0.77	0.11	2.65	1.55	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	12.26	7.61	0.65	0.26	1.94	0.26	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	44.69	29.79	0.00	0.00	2.84	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	29.38	33.22	0.96	0.96	4.32	1.44	0.36
skeletal muscle, fetal, donor1	10066-101I3	16.08	12.06	0.00	0.00	3.02	2.01	1.01
skin, adult, donor1	10074-102A2	0.00	33.93	0.00	13.57	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	32.19	22.72	1.89	1.89	4.42	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	14.34	12.01	2.00	0.00	1.33	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	47.60	40.66	3.47	1.89	14.81	10.40	5.99
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.39	30.26	6.75	0.19	4.24	3.08	2.31
small cell lung carcinoma cell line:LK-2	10541-107H1	73.18	18.79	1.98	0.82	4.12	2.14	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	34.10	50.02	2.25	0.97	12.22	7.40	5.31
small cell lung carcinoma cell line:WA-hT	10562-108A4	31.38	22.23	1.31	1.31	6.54	3.70	1.31
small intestine, adult, pool1	10024-101D6	32.01	23.05	1.19	0.36	5.02	1.91	0.60
small intestine, fetal, donor1	10064-101I1	12.78	17.69	0.00	0.49	3.19	2.21	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	27.70	15.90	1.54	1.54	5.64	2.05	1.54
smooth muscle, adult, pool1	10048-101G3	16.28	32.82	1.55	0.00	6.46	1.55	0.78
somatostatinoma cell line:QGP-1	10781-110G7	82.55	32.97	3.48	0.54	2.14	0.54	0.54
spinal cord - adult, donor10196	10181-103D1	15.60	24.78	0.46	0.46	5.28	4.13	0.69
spinal cord, adult, donor10252	10159-103A6	19.71	35.09	2.37	0.00	9.07	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	5.53	4.15	2.08	0.00	2.08	3.46	0.69
spinal cord, fetal, donor1	10056-101H2	28.66	22.56	3.66	0.00	3.66	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	17.45	13.32	1.38	0.00	4.59	3.21	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.40	18.22	2.09	0.30	2.24	1.34	1.19
spleen, adult, pool1	10025-101D7	21.59	30.62	0.99	0.33	5.18	1.32	0.88
spleen, fetal, pool1	10044-101F8	34.32	45.77	1.91	0.72	7.63	1.99	1.11
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.15	14.80	0.93	0.52	4.87	2.48	2.48
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.39	21.65	1.90	0.76	3.04	1.52	2.09
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	15.03	17.12	0.35	0.35	8.39	3.49	3.49
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.06	20.33	1.17	0.78	6.25	5.47	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	26.34	14.86	0.56	0.56	2.14	1.35	2.14
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	6.78	11.86	0.00	0.42	2.54	1.69	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	17.35	18.19	1.69	0.00	2.54	1.69	1.27
stomach, fetal, donor1	10062-101H8	49.13	41.65	0.00	0.00	1.07	2.14	0.00
submaxillary gland, adult	10202-103F4	13.67	25.07	0.00	1.14	1.71	2.85	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	108.55	0.00	0.00	54.27	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	12.67	38.63	2.28	0.83	6.23	1.87	0.42
substantia nigra, adult, donor10258	10371-105G2	8.28	7.76	1.03	0.00	2.07	3.10	2.59
substantia nigra, newborn, donor10223	10358-105E7	18.37	10.60	0.71	0.00	4.95	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	19.49	28.89	3.21	0.46	2.06	3.90	1.60
temporal lobe, adult, pool1	10031-101E4	43.06	36.62	1.70	1.02	8.82	2.46	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	27.78	36.33	3.56	0.00	4.27	2.85	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	30.33	29.45	0.88	0.00	3.96	3.08	0.88
tenocyte, donor1	11763-123H8	7.33	16.76	2.09	0.70	5.93	3.49	1.75
tenocyte, donor2	11765-123I1	6.10	5.72	0.76	0.00	0.76	1.14	1.53
tenocyte, donor3	11768-123I4	4.45	5.19	1.11	0.37	1.85	0.37	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	22.94	11.73	1.70	0.34	3.91	1.53	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	22.97	14.95	0.77	0.77	3.85	1.85	1.23
teratocarcinoma cell line:PA-1	10807-111A6	15.50	17.98	2.63	0.77	4.65	3.56	2.01
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.52	20.18	1.65	0.51	1.90	1.78	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	50.68	55.97	3.40	0.76	14.37	5.29	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.24	52.46	6.54	1.42	12.98	5.67	1.53
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.98	17.59	1.30	0.65	9.45	5.21	0.98
testis, adult, pool1	10026-101D8	27.38	31.78	2.15	0.97	8.59	1.61	1.07
testis, adult, pool2	10096-102C6	38.34	39.24	2.26	0.90	14.43	9.92	7.22
thalamus - adult, donor10196	10168-103B6	20.98	23.18	0.00	0.00	4.42	3.31	0.00
thalamus, adult, donor10252	10154-103A1	25.63	36.41	1.09	1.09	8.44	2.34	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	12.32	0.00	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.93	8.23	0.33	0.16	1.48	1.81	1.15
thalamus, newborn, donor10223	10366-105F6	18.41	6.90	2.88	0.00	5.18	2.88	1.15
throat, adult	10209-103G2	20.47	19.22	0.25	0.00	2.50	0.00	0.00
throat, fetal, donor1	10061-101H7	16.15	19.20	0.91	0.30	1.52	2.44	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	29.81	33.59	3.58	0.40	3.97	2.19	0.40
thymus, adult, pool1	10027-101D9	55.77	45.73	2.19	0.89	11.43	3.58	2.19
thymus, fetal, pool1	10043-101F7	59.12	49.98	2.81	0.73	11.12	2.70	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.16	10.11	0.93	0.00	3.99	1.60	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	20.95	19.42	0.84	0.70	4.89	2.93	2.37
thyroid, adult, pool1	10028-101E1	23.42	30.14	0.93	0.65	6.16	2.15	1.12
thyroid, fetal, donor1	10060-101H6	17.93	29.00	0.53	1.05	4.22	1.32	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	18.48	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	14.88	13.49	0.47	0.70	4.42	2.09	0.00
tongue, fetal, donor1	10059-101H5	10.64	12.22	0.39	0.00	3.15	1.18	0.39
tonsil, adult, pool1	10047-101G2	40.67	39.27	2.20	1.10	8.72	1.50	0.40
trachea, adult, pool1	10029-101E2	19.55	22.00	1.06	0.65	3.52	1.39	0.25
trachea, fetal, donor1	10058-101H4	15.77	33.08	1.15	1.15	2.69	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	17.36	6.73	0.00	0.35	1.42	2.48	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	34.75	20.67	1.72	0.41	3.44	1.52	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	23.03	31.81	2.66	0.94	10.65	5.64	3.76
tridermal teratoma cell line:HGRT	10694-109G1	28.54	58.98	9.51	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	7.70	11.09	1.27	0.17	2.12	1.27	0.85
umbilical cord, fetal, donor1	10057-101H3	14.61	14.61	0.00	0.00	4.17	2.09	0.00
uterus, adult, pool1	10100-102D1	11.77	26.11	1.54	0.17	6.14	1.54	1.88
uterus, fetal, donor1	10055-101H1	11.77	23.04	2.56	0.51	4.10	1.02	0.51
vagina, adult	10204-103F6	25.85	34.89	1.29	0.65	6.46	1.29	0.65
vein, adult	10191-103E2	24.33	26.96	0.88	0.00	3.95	1.75	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.08	11.22	0.53	0.27	2.40	0.80	1.34

Property "Nearest transcripts" (as page type) with input value "ENST00000597315.5:-110 BC038988:-162 BC067129:-166 BC091649:-182 BC047888:-198 ENST00000679869.1:-206 NM_001379291.1:-206 NM_001379292.1:-206 NM_001330384.2:-206 LF210778:-210 MA446355:-210 BC035266:-210 ENST00000360016.9:-212 ENST00000601941.1:416 ENST00000594841.5:417 AK307664:417 BC030158:433" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.